| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | SUMO ligase activity | 6.71e-06 | 20 | 279 | 5 | GO:0061665 | |
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | ZBTB38 ZBTB20 ZNF391 PER1 ZNF217 ZNF225 ZNF829 ZNF518A ZNF331 ZNF506 USP3 ZNF574 ZNF567 ZNF473 ZNF570 APP ZNF883 ZIM3 AR ZNF248 ZNF404 ZNF710 CRY1 ZNF711 PKNOX2 ZNF34 GTF2B OVOL1 ZNF341 LMX1B ZNF277 ZNF665 ZFHX3 RORC ZNF333 ZNF281 ZNF415 KDM1A ZNF639 | 7.05e-05 | 1459 | 279 | 39 | GO:0000977 |
| GeneOntologyMolecularFunction | SUMO transferase activity | 1.36e-04 | 36 | 279 | 5 | GO:0019789 | |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity involved SA node cell action potential | 1.95e-04 | 2 | 279 | 2 | GO:0086059 | |
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | ZBTB38 ZBTB20 PER1 ZNF217 ZNF225 ZNF829 ZNF331 ZNF506 USP3 ZNF574 ZNF567 ZNF473 ZNF570 APP ZNF883 ZIM3 AR ZNF710 CRY1 ZNF711 PKNOX2 ZNF34 OVOL1 ZNF341 ZNF277 ZNF665 ZFHX3 RORC ZNF333 ZNF281 ZNF415 KDM1A ZNF639 | 3.05e-04 | 1244 | 279 | 33 | GO:0000978 |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 3.25e-04 | 188 | 279 | 10 | GO:0005201 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on DNA | RSF1 ERVK-10 PTBP1 DDX1 HELB POLK POLE XRCC2 XRCC4 RFC5 THAP9 CRY1 | 3.36e-04 | 262 | 279 | 12 | GO:0140097 |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | ZBTB38 ZBTB20 PER1 ZNF217 ZNF225 ZNF829 ZNF331 ZNF506 USP3 ZNF574 ZNF567 ZNF473 ZNF570 APP ZNF883 ZIM3 AR ZNF710 CRY1 ZNF711 PKNOX2 ZNF34 OVOL1 ZNF341 ZNF277 ZNF665 ZFHX3 RORC ZNF333 ZNF281 ZNF415 KDM1A ZNF639 | 4.46e-04 | 1271 | 279 | 33 | GO:0000987 |
| GeneOntologyMolecularFunction | adenosylhomocysteinase activity | 5.78e-04 | 3 | 279 | 2 | GO:0004013 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on carbon-sulfur bonds | 5.78e-04 | 3 | 279 | 2 | GO:0046508 | |
| GeneOntologyMolecularFunction | N-acetylglucosamine-6-sulfatase activity | 5.78e-04 | 3 | 279 | 2 | GO:0008449 | |
| GeneOntologyBiologicalProcess | nuclear export | RGPD4 DDX19B AHCYL1 MCM3AP RGPD3 PKD1 NUP153 RANBP2 RGPD8 NUP98 TGFB1 RANBP17 XPO7 | 1.63e-06 | 185 | 281 | 13 | GO:0051168 |
| GeneOntologyBiologicalProcess | intracellular protein transport | RGPD4 AHCYL1 CLTCL1 ZFYVE16 CFL1 SEC24A MPDZ TSC2 ITGB1 RGPD3 PKD1 HERC2 NUP153 RGPD5 RANBP2 APPBP2 RGPD8 COPA VPS8 NUP98 CTSA TGFB1 RANBP17 WDR11 BECN1 TNPO3 XPO7 | 3.60e-06 | 740 | 281 | 27 | GO:0006886 |
| GeneOntologyBiologicalProcess | positive regulation of glucokinase activity | 4.03e-06 | 9 | 281 | 4 | GO:0033133 | |
| GeneOntologyBiologicalProcess | NLS-bearing protein import into nucleus | 5.94e-06 | 20 | 281 | 5 | GO:0006607 | |
| GeneOntologyBiologicalProcess | positive regulation of hexokinase activity | 6.64e-06 | 10 | 281 | 4 | GO:1903301 | |
| GeneOntologyBiologicalProcess | phospholipid transport | 1.47e-05 | 106 | 281 | 9 | GO:0015914 | |
| GeneOntologyBiologicalProcess | protein import into nucleus | RGPD4 CFL1 TSC2 RGPD3 NUP153 RGPD5 RANBP2 RGPD8 NUP98 TGFB1 RANBP17 TNPO3 | 1.58e-05 | 195 | 281 | 12 | GO:0006606 |
| GeneOntologyBiologicalProcess | nuclear transport | RGPD4 DDX19B AHCYL1 CFL1 TSC2 MCM3AP RGPD3 PKD1 NUP153 RGPD5 RANBP2 RGPD8 NUP98 TGFB1 RANBP17 TNPO3 XPO7 | 1.86e-05 | 378 | 281 | 17 | GO:0051169 |
| GeneOntologyBiologicalProcess | nucleocytoplasmic transport | RGPD4 DDX19B AHCYL1 CFL1 TSC2 MCM3AP RGPD3 PKD1 NUP153 RGPD5 RANBP2 RGPD8 NUP98 TGFB1 RANBP17 TNPO3 XPO7 | 1.86e-05 | 378 | 281 | 17 | GO:0006913 |
| GeneOntologyBiologicalProcess | import into nucleus | RGPD4 CFL1 TSC2 RGPD3 NUP153 RGPD5 RANBP2 RGPD8 NUP98 TGFB1 RANBP17 TNPO3 | 2.14e-05 | 201 | 281 | 12 | GO:0051170 |
| GeneOntologyBiologicalProcess | regulation of glucokinase activity | 2.19e-05 | 13 | 281 | 4 | GO:0033131 | |
| GeneOntologyBiologicalProcess | regulation of hexokinase activity | 3.03e-05 | 14 | 281 | 4 | GO:1903299 | |
| GeneOntologyBiologicalProcess | intracellular transport | RGPD4 DDX19B AHCYL1 CLTCL1 ZFYVE16 CFL1 SEC24A LCA5L MPDZ TSC2 ITGB1 MCM3AP RGPD3 PKD1 HERC2 KIF17 TAP2 NUP153 RGPD5 RANBP2 APPBP2 RGPD8 COPA SYNE1 VPS8 NUP98 ARL8A APP CTSA CERT1 WDPCP TGFB1 RANBP17 OSBP WDR11 ARL8B LMX1B BECN1 TNPO3 XPO7 | 3.23e-05 | 1496 | 281 | 40 | GO:0046907 |
| GeneOntologyBiologicalProcess | extracellular matrix organization | SPINT1 MATN2 ITGB1 SULF2 SULF1 ADAMTS16 MANSC4 SPINK5 APBB2 APP ADAMTSL3 TNFRSF11B TGFB1 TGFBI LMX1B EGFLAM | 6.54e-05 | 377 | 281 | 16 | GO:0030198 |
| GeneOntologyBiologicalProcess | extracellular structure organization | SPINT1 MATN2 ITGB1 SULF2 SULF1 ADAMTS16 MANSC4 SPINK5 APBB2 APP ADAMTSL3 TNFRSF11B TGFB1 TGFBI LMX1B EGFLAM | 6.75e-05 | 378 | 281 | 16 | GO:0043062 |
| GeneOntologyBiologicalProcess | external encapsulating structure organization | SPINT1 MATN2 ITGB1 SULF2 SULF1 ADAMTS16 MANSC4 SPINK5 APBB2 APP ADAMTSL3 TNFRSF11B TGFB1 TGFBI LMX1B EGFLAM | 6.96e-05 | 379 | 281 | 16 | GO:0045229 |
| GeneOntologyBiologicalProcess | phospholipid translocation | 1.00e-04 | 55 | 281 | 6 | GO:0045332 | |
| GeneOntologyBiologicalProcess | lipid translocation | 1.64e-04 | 60 | 281 | 6 | GO:0034204 | |
| GeneOntologyBiologicalProcess | establishment of RNA localization | RGPD4 DDX19B MCM3AP RGPD3 NUP153 RANBP2 RGPD8 NUP98 RANBP17 ATM | 1.71e-04 | 178 | 281 | 10 | GO:0051236 |
| GeneOntologyBiologicalProcess | mRNA transport | 1.72e-04 | 145 | 281 | 9 | GO:0051028 | |
| GeneOntologyBiologicalProcess | esophagus smooth muscle contraction | 1.85e-04 | 2 | 281 | 2 | GO:0014846 | |
| GeneOntologyBiologicalProcess | N-acetylneuraminate biosynthetic process | 1.85e-04 | 2 | 281 | 2 | GO:0046380 | |
| GeneOntologyBiologicalProcess | N-acetylglucosamine biosynthetic process | 1.85e-04 | 2 | 281 | 2 | GO:0006045 | |
| GeneOntologyBiologicalProcess | response to radiation | NOC2L PER1 ZZEF1 ITGB1 PTPRC POLK CACNA1F KAT5 SYNE1 XRCC2 XRCC4 APP CRB1 CRY1 TGFB1 RP1 ATM KDM1A | 2.01e-04 | 503 | 281 | 18 | GO:0009314 |
| GeneOntologyBiologicalProcess | somatic diversification of immune receptors | 2.47e-04 | 91 | 281 | 7 | GO:0002200 | |
| GeneOntologyBiologicalProcess | regulation of membrane lipid distribution | 2.55e-04 | 65 | 281 | 6 | GO:0097035 | |
| GeneOntologyBiologicalProcess | chordate embryonic development | SPINT1 CFL1 KBTBD8 TSC2 KEAP1 ITGB1 LRP1B TBC1D32 SULF2 SULF1 EIF2S2 PKD1 PDS5A ADGRF5 ATP11A HECTD1 KAT5 XRCC2 XRCC4 CERT1 AR WDPCP ZFPM2 TGFB1 ATM RPA1 | 2.95e-04 | 906 | 281 | 26 | GO:0043009 |
| GeneOntologyBiologicalProcess | protein modification by small protein conjugation or removal | TRPC4AP TRIM75 KBTBD8 KEAP1 USP9Y ZZEF1 RNF217 HERC2P3 USP31 PIAS3 ANAPC1 MINAR1 USP35 HERC2 HECTD1 USP3 USP50 USP49 RANBP2 APPBP2 TRIB2 ATG7 USP24 TRIM3 CRY1 NUB1 RNF122 KDM1A | 2.97e-04 | 1009 | 281 | 28 | GO:0070647 |
| GeneOntologyCellularComponent | nuclear pore nuclear basket | 2.17e-09 | 18 | 283 | 7 | GO:0044615 | |
| GeneOntologyCellularComponent | annulate lamellae | 1.60e-08 | 14 | 283 | 6 | GO:0005642 | |
| GeneOntologyCellularComponent | nuclear pore cytoplasmic filaments | 1.05e-07 | 10 | 283 | 5 | GO:0044614 | |
| GeneOntologyCellularComponent | nuclear pore | RGPD4 DDX19B MCM3AP RGPD3 NUP153 RGPD5 RANBP2 RGPD8 NUP98 RANBP17 XPO7 | 1.25e-07 | 101 | 283 | 11 | GO:0005643 |
| GeneOntologyCellularComponent | nuclear inclusion body | 1.93e-07 | 20 | 283 | 6 | GO:0042405 | |
| GeneOntologyCellularComponent | cytoplasmic periphery of the nuclear pore complex | 2.21e-06 | 8 | 283 | 4 | GO:1990723 | |
| GeneOntologyCellularComponent | inclusion body | 3.64e-06 | 90 | 283 | 9 | GO:0016234 | |
| GeneOntologyCellularComponent | SUMO ligase complex | 1.64e-04 | 21 | 283 | 4 | GO:0106068 | |
| GeneOntologyCellularComponent | integrin alpha6-beta1 complex | 1.83e-04 | 2 | 283 | 2 | GO:0034675 | |
| GeneOntologyCellularComponent | site of double-strand break | 4.50e-04 | 101 | 283 | 7 | GO:0035861 | |
| GeneOntologyCellularComponent | site of DNA damage | 5.67e-04 | 137 | 283 | 8 | GO:0090734 | |
| MousePheno | increased lung tumor incidence | 5.30e-06 | 107 | 213 | 10 | MP:0008014 | |
| MousePheno | increased respiratory system tumor incidence | 5.30e-06 | 107 | 213 | 10 | MP:0010298 | |
| MousePheno | abnormal circulating potassium level | ZBTB20 MPDZ ATP8B1 ZZEF1 USP31 ADAMTS16 MTMR3 CTSA AR TGFB1 PPP2R2B NUB1 | 1.21e-05 | 171 | 213 | 12 | MP:0002668 |
| MousePheno | abnormal potassium level | ZBTB20 MPDZ ATP8B1 ZZEF1 USP31 ADAMTS16 MTMR3 CTSA AR TGFB1 PPP2R2B NUB1 | 4.69e-05 | 196 | 213 | 12 | MP:0020887 |
| MousePheno | abnormal potassium ion homeostasis | ZBTB20 MPDZ ATP8B1 ZZEF1 USP31 ADAMTS16 MTMR3 CTSA AR TGFB1 PPP2R2B NUB1 | 5.18e-05 | 198 | 213 | 12 | MP:0011978 |
| MousePheno | abnormal podocyte physiology | 6.74e-05 | 6 | 213 | 3 | MP:0011863 | |
| MousePheno | elevated level of mitotic sister chromatid exchange | 8.26e-05 | 16 | 213 | 4 | MP:0003701 | |
| MousePheno | increased circulating potassium level | 9.67e-05 | 121 | 213 | 9 | MP:0005627 | |
| Domain | Znf_C2H2-like | ZBTB38 ZBTB20 ZNF391 ZBTB8B ZNF217 ZNF225 ZNF829 ZNF518A ZNF331 ZNF506 ZNF574 ZNF567 ZNF473 ZNF570 ZNF883 ZIM3 ZFPM2 ZNF248 ZNF404 ZNF710 ZNF711 RLF ZMAT3 ZNF34 OVOL1 ZNF341 ZNF277 ZNF665 ZNF706 HELZ2 ZFHX3 ZNF333 ZNF281 ZNF415 ZNF639 ZNF292 | 2.85e-09 | 796 | 278 | 36 | IPR015880 |
| Domain | zf-C2H2 | ZBTB38 ZBTB20 ZNF391 ZBTB8B ZNF217 ZNF225 ZNF829 ZNF518A ZNF331 ZNF506 ZNF574 ZNF567 ZNF473 ZNF570 ZNF883 ZIM3 ZFPM2 ZNF248 ZNF404 ZNF710 ZNF711 RLF ZNF34 OVOL1 ZNF341 ZNF277 ZNF665 ZFHX3 ZNF333 ZNF281 ZNF415 ZNF639 ZNF292 | 3.94e-09 | 693 | 278 | 33 | PF00096 |
| Domain | ZnF_C2H2 | ZBTB38 ZBTB20 ZNF391 ZBTB8B ZNF217 ZNF225 ZNF829 ZNF518A ZNF331 ZNF506 ZNF574 ZNF567 ZNF473 ZNF570 ZNF883 ZIM3 ZFPM2 ZNF248 ZNF404 ZNF710 ZNF711 RLF ZMAT3 ZNF34 OVOL1 ZNF341 ZNF277 ZNF665 ZNF706 HELZ2 ZFHX3 ZNF333 ZNF281 ZNF415 ZNF639 ZNF292 | 4.23e-09 | 808 | 278 | 36 | SM00355 |
| Domain | ZINC_FINGER_C2H2_2 | ZBTB38 ZBTB20 ZNF391 ZBTB8B ZNF217 ZNF225 ZNF829 ZNF518A ZNF331 ZNF506 ZNF574 ZNF567 ZNF473 ZNF570 ZNF883 ZIM3 ZFPM2 ZNF248 ZNF404 ZNF710 ZNF711 RLF ZNF34 OVOL1 ZNF341 ZNF277 ZNF665 ZNF706 HELZ2 ZFHX3 ZNF333 ZNF281 ZNF415 ZNF639 ZNF292 | 5.02e-09 | 775 | 278 | 35 | PS50157 |
| Domain | ZINC_FINGER_C2H2_1 | ZBTB38 ZBTB20 ZNF391 ZBTB8B ZNF217 ZNF225 ZNF829 ZNF518A ZNF331 ZNF506 ZNF574 ZNF567 ZNF473 ZNF570 ZNF883 ZIM3 ZFPM2 ZNF248 ZNF404 ZNF710 ZNF711 RLF ZNF34 OVOL1 ZNF341 ZNF277 ZNF665 ZNF706 HELZ2 ZFHX3 ZNF333 ZNF281 ZNF415 ZNF639 ZNF292 | 5.37e-09 | 777 | 278 | 35 | PS00028 |
| Domain | Znf_C2H2/integrase_DNA-bd | ZBTB38 ZBTB20 ZNF391 ZBTB8B ZNF217 ZNF225 ZNF829 ZNF518A ZNF331 ZNF506 ZNF574 ZNF567 ZNF473 ZNF570 ZNF883 ZIM3 ZFPM2 ZNF248 ZNF404 ZNF710 ZNF711 RLF ZNF34 OVOL1 ZNF341 ZNF665 ZFHX3 ZNF333 ZNF281 ZNF415 ZNF639 ZNF292 | 1.49e-08 | 694 | 278 | 32 | IPR013087 |
| Domain | - | ZBTB38 ZBTB20 ZNF391 ZBTB8B ZNF217 ZNF225 ZNF829 ZNF331 ZNF506 ZNF574 ZNF567 ZNF473 ZNF570 ZNF883 ZIM3 ZFPM2 ZNF248 ZNF404 ZNF710 ZNF711 RLF ZNF34 OVOL1 ZNF341 ZNF665 ZFHX3 ZNF333 ZNF281 ZNF415 ZNF639 ZNF292 | 3.19e-08 | 679 | 278 | 31 | 3.30.160.60 |
| Domain | Znf_C2H2 | ZBTB38 ZBTB20 ZNF391 ZBTB8B ZNF217 ZNF225 ZNF829 ZNF518A ZNF331 ZNF506 ZNF574 ZNF567 ZNF473 ZNF570 ZNF883 ZIM3 ZFPM2 ZNF248 ZNF404 ZNF710 ZNF711 RLF ZNF34 OVOL1 ZNF341 ZNF277 ZNF665 ZNF706 ZFHX3 ZNF333 ZNF281 ZNF415 ZNF639 ZNF292 | 4.38e-08 | 805 | 278 | 34 | IPR007087 |
| Domain | ARM-type_fold | TRPC4AP CLTCL1 NOC2L TSC2 USP9Y PIK3C2B ANKAR PKP1 PDS5A USP35 HECTD1 MROH9 RTTN USP24 ECPAS RANBP17 HEATR6 ATM TNPO3 XPO7 | 1.92e-07 | 339 | 278 | 20 | IPR016024 |
| Domain | Ran_BP1 | 5.13e-07 | 12 | 278 | 5 | PF00638 | |
| Domain | RANBD1 | 5.13e-07 | 12 | 278 | 5 | PS50196 | |
| Domain | C8 | 5.13e-07 | 12 | 278 | 5 | PF08742 | |
| Domain | TIL | 5.13e-07 | 12 | 278 | 5 | PF01826 | |
| Domain | RanBD | 8.23e-07 | 13 | 278 | 5 | SM00160 | |
| Domain | Ran_bind_dom | 8.23e-07 | 13 | 278 | 5 | IPR000156 | |
| Domain | C8 | 8.23e-07 | 13 | 278 | 5 | SM00832 | |
| Domain | Unchr_dom_Cys-rich | 8.23e-07 | 13 | 278 | 5 | IPR014853 | |
| Domain | TIL_dom | 1.26e-06 | 14 | 278 | 5 | IPR002919 | |
| Domain | VWF_type-D | 2.69e-06 | 16 | 278 | 5 | IPR001846 | |
| Domain | VWFD | 2.69e-06 | 16 | 278 | 5 | PS51233 | |
| Domain | VWD | 2.69e-06 | 16 | 278 | 5 | SM00216 | |
| Domain | VWD | 2.69e-06 | 16 | 278 | 5 | PF00094 | |
| Domain | VWC_out | 6.91e-06 | 19 | 278 | 5 | SM00215 | |
| Domain | PP2A_PR55 | 1.29e-05 | 4 | 278 | 3 | IPR000009 | |
| Domain | PR55_2 | 1.29e-05 | 4 | 278 | 3 | PS01025 | |
| Domain | PR55_1 | 1.29e-05 | 4 | 278 | 3 | PS01024 | |
| Domain | PP2A_PR55_CS | 1.29e-05 | 4 | 278 | 3 | IPR018067 | |
| Domain | GRIP | 1.46e-05 | 11 | 278 | 4 | PF01465 | |
| Domain | Grip | 1.46e-05 | 11 | 278 | 4 | SM00755 | |
| Domain | TPR-contain_dom | RGPD4 SPAG1 TRANK1 RGPD3 RGPD5 RANBP2 APPBP2 RGPD8 TTC27 CABIN1 EDRF1 | 1.56e-05 | 150 | 278 | 11 | IPR013026 |
| Domain | GRIP | 2.16e-05 | 12 | 278 | 4 | PS50913 | |
| Domain | GRIP_dom | 2.16e-05 | 12 | 278 | 4 | IPR000237 | |
| Domain | TPR | RGPD4 SPAG1 TRANK1 RGPD3 RGPD5 RANBP2 APPBP2 RGPD8 TTC27 CABIN1 EDRF1 | 3.79e-05 | 165 | 278 | 11 | PS50005 |
| Domain | TPR_REGION | RGPD4 SPAG1 TRANK1 RGPD3 RGPD5 RANBP2 APPBP2 RGPD8 TTC27 CABIN1 EDRF1 | 3.79e-05 | 165 | 278 | 11 | PS50293 |
| Domain | TPR-like_helical_dom | RGPD4 SPAG1 CLTCL1 TRANK1 RGPD3 RGPD5 RANBP2 APPBP2 RGPD8 TTC27 NUB1 CABIN1 EDRF1 | 4.93e-05 | 233 | 278 | 13 | IPR011990 |
| Domain | USP_CS | 5.52e-05 | 66 | 278 | 7 | IPR018200 | |
| Domain | ARM-like | TSC2 USP9Y ANKAR PKP1 PDS5A USP35 HECTD1 MROH9 RTTN ECPAS RANBP17 HEATR6 TNPO3 XPO7 | 5.65e-05 | 270 | 278 | 14 | IPR011989 |
| Domain | USP_1 | 8.08e-05 | 70 | 278 | 7 | PS00972 | |
| Domain | UCH | 8.85e-05 | 71 | 278 | 7 | PF00443 | |
| Domain | USP_2 | 8.85e-05 | 71 | 278 | 7 | PS00973 | |
| Domain | EGF_CA | 8.87e-05 | 122 | 278 | 9 | SM00179 | |
| Domain | USP_dom | 9.68e-05 | 72 | 278 | 7 | IPR028889 | |
| Domain | Peptidase_C19_UCH | 9.68e-05 | 72 | 278 | 7 | IPR001394 | |
| Domain | USP_3 | 9.68e-05 | 72 | 278 | 7 | PS50235 | |
| Domain | EGF-like_Ca-bd_dom | 1.01e-04 | 124 | 278 | 9 | IPR001881 | |
| Domain | TB | 1.09e-04 | 7 | 278 | 3 | PF00683 | |
| Domain | GCC2_Rab_bind | 1.09e-04 | 7 | 278 | 3 | IPR032023 | |
| Domain | Rab_bind | 1.09e-04 | 7 | 278 | 3 | PF16704 | |
| Domain | EGF | 1.14e-04 | 126 | 278 | 9 | PF00008 | |
| Domain | ASX_HYDROXYL | 1.24e-04 | 100 | 278 | 8 | PS00010 | |
| Domain | TPR | 1.36e-04 | 129 | 278 | 9 | SM00028 | |
| Domain | TPR_repeat | 1.72e-04 | 133 | 278 | 9 | IPR019734 | |
| Domain | - | 1.73e-04 | 8 | 278 | 3 | 3.90.290.10 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 1.86e-04 | 106 | 278 | 8 | IPR000152 | |
| Domain | EGF | MATN2 LRP1B F9 NTNG2 FBN1 CRELD2 TECTA CRB1 TMEFF1 EGFLAM LTBP2 FBN3 | 2.20e-04 | 235 | 278 | 12 | SM00181 |
| Domain | EGF_3 | MATN2 SSPOP LRP1B F9 NTNG2 FBN1 CRELD2 CRB1 TMEFF1 EGFLAM LTBP2 FBN3 | 2.20e-04 | 235 | 278 | 12 | PS50026 |
| Domain | Extracellular_sulfatase | 2.21e-04 | 2 | 278 | 2 | IPR014615 | |
| Domain | Extracellular_sulfatase_C | 2.21e-04 | 2 | 278 | 2 | IPR024609 | |
| Domain | DUF3740 | 2.21e-04 | 2 | 278 | 2 | PF12548 | |
| Domain | TB_dom | 2.56e-04 | 9 | 278 | 3 | IPR017878 | |
| Domain | TB | 2.56e-04 | 9 | 278 | 3 | PS51364 | |
| Domain | - | RGPD4 SPAG1 CLTCL1 TRANK1 RGPD3 RANBP2 APPBP2 RGPD8 TTC27 CABIN1 EDRF1 | 2.85e-04 | 207 | 278 | 11 | 1.25.40.10 |
| Domain | VDCCAlpha1 | 3.62e-04 | 10 | 278 | 3 | IPR002077 | |
| Domain | - | 3.62e-04 | 10 | 278 | 3 | 1.10.220.60 | |
| Domain | EGF-like_dom | MATN2 LRP1B F9 NTNG2 FBN1 CRELD2 TECTA CRB1 TMEFF1 EGFLAM LTBP2 FBN3 | 3.72e-04 | 249 | 278 | 12 | IPR000742 |
| Domain | VWF_dom | 3.82e-04 | 42 | 278 | 5 | IPR001007 | |
| Domain | EGF_1 | ITGB1 SSPOP LRP1B F9 NTNG2 FBN1 CRELD2 CRB1 TMEFF1 EGFLAM LTBP2 FBN3 | 4.61e-04 | 255 | 278 | 12 | PS00022 |
| Domain | Cys_knot_C | 4.75e-04 | 25 | 278 | 4 | IPR006207 | |
| Domain | CTCK_2 | 4.75e-04 | 25 | 278 | 4 | PS01225 | |
| Domain | - | TSC2 ANKAR PKP1 PDS5A HECTD1 MROH9 RTTN ECPAS RANBP17 HEATR6 TNPO3 | 5.15e-04 | 222 | 278 | 11 | 1.25.10.10 |
| Domain | cEGF | 5.55e-04 | 26 | 278 | 4 | PF12662 | |
| Domain | cEGF | 5.55e-04 | 26 | 278 | 4 | IPR026823 | |
| Domain | EGF-like_CS | MATN2 ITGB1 LRP1B F9 NTNG2 FBN1 CRELD2 CRB1 TMEFF1 EGFLAM LTBP2 FBN3 | 5.67e-04 | 261 | 278 | 12 | IPR013032 |
| Domain | EGF_Ca-bd_CS | 6.16e-04 | 97 | 278 | 7 | IPR018097 | |
| Domain | EGF_2 | MATN2 SSPOP LRP1B F9 NTNG2 FBN1 CRELD2 CRB1 TMEFF1 EGFLAM LTBP2 FBN3 | 6.48e-04 | 265 | 278 | 12 | PS01186 |
| Domain | AdoHcyase_NAD | 6.56e-04 | 3 | 278 | 2 | SM00997 | |
| Domain | AdoHcyase | 6.56e-04 | 3 | 278 | 2 | SM00996 | |
| Domain | AdoHcyase_NAD | 6.56e-04 | 3 | 278 | 2 | PF00670 | |
| Domain | CAC1F_C | 6.56e-04 | 3 | 278 | 2 | IPR031688 | |
| Domain | ADOHCYASE_1 | 6.56e-04 | 3 | 278 | 2 | PS00738 | |
| Domain | ADOHCYASE_2 | 6.56e-04 | 3 | 278 | 2 | PS00739 | |
| Domain | S-Ado-L-homoCys_hydrolase_CS | 6.56e-04 | 3 | 278 | 2 | IPR020082 | |
| Domain | Adenosylhomocysteinase | 6.56e-04 | 3 | 278 | 2 | IPR000043 | |
| Domain | AdoHcyase | 6.56e-04 | 3 | 278 | 2 | PF05221 | |
| Domain | Ado_hCys_hydrolase_NAD-bd | 6.56e-04 | 3 | 278 | 2 | IPR015878 | |
| Domain | CAC1F_C | 6.56e-04 | 3 | 278 | 2 | PF16885 | |
| Domain | FBN | 6.56e-04 | 3 | 278 | 2 | IPR011398 | |
| Domain | EGF_CA | 6.96e-04 | 99 | 278 | 7 | PS01187 | |
| Domain | LDLRA_1 | 7.15e-04 | 48 | 278 | 5 | PS01209 | |
| Domain | LDLRA_2 | 7.87e-04 | 49 | 278 | 5 | PS50068 | |
| Domain | zf-C2H2_6 | ZNF391 ZNF225 ZNF331 ZNF506 ZNF574 ZNF567 ZNF473 ZNF570 ZNF883 ZIM3 ZNF404 ZNF710 ZNF333 | 8.99e-04 | 314 | 278 | 13 | PF13912 |
| Domain | MIB_HERC2 | 1.30e-03 | 4 | 278 | 2 | PS51416 | |
| Domain | MIB_HERC2 | 1.30e-03 | 4 | 278 | 2 | PF06701 | |
| Domain | VDCC_L_a1su | 1.30e-03 | 4 | 278 | 2 | IPR005446 | |
| Domain | Mib_Herc2 | 1.30e-03 | 4 | 278 | 2 | IPR010606 | |
| Domain | MANEC | 1.30e-03 | 4 | 278 | 2 | PF07502 | |
| Domain | - | 1.57e-03 | 57 | 278 | 5 | 1.20.120.350 | |
| Domain | Channel_four-helix_dom | 1.57e-03 | 57 | 278 | 5 | IPR027359 | |
| Domain | EGF_CA | 1.79e-03 | 86 | 278 | 6 | PF07645 | |
| Domain | MANSC_N | 2.14e-03 | 5 | 278 | 2 | IPR011106 | |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_DAMAGE_RESPONSE_AND_REPAIR_PROTEINS | 3.23e-06 | 84 | 203 | 9 | MM14929 | |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_REPLICATION_PROTEINS | 7.84e-06 | 51 | 203 | 7 | MM15151 | |
| Pathway | REACTOME_HDR_THROUGH_HOMOLOGOUS_RECOMBINATION_HRR | 2.10e-05 | 59 | 203 | 7 | MM15283 | |
| Pathway | REACTOME_NUCLEAR_PORE_COMPLEX_NPC_DISASSEMBLY | 2.11e-05 | 40 | 203 | 6 | MM14945 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_SMALL_RNAS | 2.45e-05 | 41 | 203 | 6 | MM15200 | |
| Pathway | REACTOME_SUMOYLATION_OF_SUMOYLATION_PROTEINS | 2.82e-05 | 42 | 203 | 6 | MM15039 | |
| Pathway | REACTOME_TRANSPORT_OF_THE_SLBP_DEPENDANT_MATURE_MRNA | 3.24e-05 | 43 | 203 | 6 | MM14609 | |
| Pathway | REACTOME_SUMOYLATION | RGPD4 PIAS3 RGPD3 HERC2 NUP153 RANBP2 RGPD8 NUP98 XRCC4 AR RPA1 | 3.35e-05 | 169 | 203 | 11 | MM14919 |
| Pathway | REACTOME_SUMOYLATION_OF_UBIQUITINYLATION_PROTEINS | 5.44e-05 | 47 | 203 | 6 | MM14939 | |
| Pathway | REACTOME_HDR_THROUGH_HOMOLOGOUS_RECOMBINATION_HRR | 6.44e-05 | 70 | 203 | 7 | M27570 | |
| Pathway | REACTOME_GENE_SILENCING_BY_RNA | 6.91e-05 | 49 | 203 | 6 | MM14837 | |
| Pathway | REACTOME_TRANSPORT_OF_MATURE_MRNAS_DERIVED_FROM_INTRONLESS_TRANSCRIPTS | 7.76e-05 | 50 | 203 | 6 | MM14610 | |
| Pathway | REACTOME_REGULATION_OF_HSF1_MEDIATED_HEAT_SHOCK_RESPONSE | 8.44e-05 | 73 | 203 | 7 | MM14948 | |
| Pathway | KEGG_MEDICUS_REFERENCE_HOMOLOGOUS_RECOMBINATION | 1.01e-04 | 33 | 203 | 5 | M47842 | |
| Pathway | BIOCARTA_RANBP2_PATHWAY | 1.09e-04 | 18 | 203 | 4 | MM1549 | |
| Pathway | REACTOME_NUCLEAR_ENVELOPE_BREAKDOWN | 1.33e-04 | 55 | 203 | 6 | MM14917 | |
| Pathway | REACTOME_MOLECULES_ASSOCIATED_WITH_ELASTIC_FIBRES | 1.77e-04 | 37 | 203 | 5 | M27134 | |
| Pathway | REACTOME_GLUCOSE_METABOLISM | 1.77e-04 | 82 | 203 | 7 | MM15394 | |
| Pathway | REACTOME_REGULATION_OF_HSF1_MEDIATED_HEAT_SHOCK_RESPONSE | 1.77e-04 | 82 | 203 | 7 | M27250 | |
| Pathway | REACTOME_SUMOYLATION_OF_RNA_BINDING_PROTEINS | 1.80e-04 | 58 | 203 | 6 | MM15149 | |
| Pathway | REACTOME_SNRNP_ASSEMBLY | 1.80e-04 | 58 | 203 | 6 | MM14736 | |
| Pathway | REACTOME_GAP_FILLING_DNA_REPAIR_SYNTHESIS_AND_LIGATION_IN_GG_NER | 2.49e-04 | 22 | 203 | 4 | MM15303 | |
| Pathway | REACTOME_DNA_DOUBLE_STRAND_BREAK_REPAIR | 2.63e-04 | 146 | 203 | 9 | MM15292 | |
| Pathway | REACTOME_HOMOLOGY_DIRECTED_REPAIR | 2.71e-04 | 116 | 203 | 8 | MM15294 | |
| Pathway | REACTOME_SUMOYLATION_OF_CHROMATIN_ORGANIZATION_PROTEINS | 3.37e-04 | 65 | 203 | 6 | MM15147 | |
| Pathway | REACTOME_CELLULAR_RESPONSE_TO_HEAT_STRESS | 3.61e-04 | 92 | 203 | 7 | MM14951 | |
| Pathway | REACTOME_HOMOLOGOUS_DNA_PAIRING_AND_STRAND_EXCHANGE | 3.64e-04 | 43 | 203 | 5 | M27588 | |
| Pathway | REACTOME_ELASTIC_FIBRE_FORMATION | 4.06e-04 | 44 | 203 | 5 | M26969 | |
| Pathway | REACTOME_GAP_FILLING_DNA_REPAIR_SYNTHESIS_AND_LIGATION_IN_GG_NER | 4.17e-04 | 25 | 203 | 4 | M27593 | |
| Pathway | REACTOME_CELLULAR_RESPONSE_TO_HEAT_STRESS | 6.35e-04 | 101 | 203 | 7 | M27253 | |
| Pathway | REACTOME_DNA_DOUBLE_STRAND_BREAK_REPAIR | 7.99e-04 | 170 | 203 | 9 | M27582 | |
| Pathway | REACTOME_DISEASES_OF_DNA_REPAIR | 8.09e-04 | 51 | 203 | 5 | M29854 | |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_DAMAGE_RESPONSE_AND_REPAIR_PROTEINS | 8.40e-04 | 77 | 203 | 6 | M27226 | |
| Pathway | WP_PRIMARY_OVARIAN_INSUFFICIENCY | 9.43e-04 | 174 | 203 | 9 | M48058 | |
| Pathway | REACTOME_HOMOLOGY_DIRECTED_REPAIR | 9.50e-04 | 140 | 203 | 8 | M27584 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_VGCC_CA2_APOPTOTIC_PATHWAY_N01004 | 9.53e-04 | 14 | 203 | 3 | M47692 | |
| Pathway | REACTOME_SYNDECAN_INTERACTIONS | 9.53e-04 | 14 | 203 | 3 | MM14923 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | TRPC4AP ZBTB20 MYO9A ATXN7L1 ATP8B1 PCGF3 ITGB1 SSPOP ZNF331 PTPRG RIN2 ANKAR EIF2B4 KCNMA1 ATP11A POLK ZDHHC13 HECTD1 USP3 BRMS1 ATG7 PTBP2 PSCA APBB2 CHCHD6 AHCYL2 XRCC2 APP TECTA ECPAS ECH1 CERT1 AR ZNF248 RLF PKNOX2 RANBP17 PPP2R2C WDR11 MACF1 ZFHX3 GREB1 PNPLA7 XPO7 | 2.87e-13 | 1489 | 289 | 44 | 28611215 |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | AHCYL1 MYO9A NOC2L CFL1 ACP1 RSF1 PTBP1 DDX1 MCM3AP EIF2B4 A2ML1 EIF2S2 UGDH PKP1 PDS5A DDX43 HERC2 FHL2 ALDOA USP3 RANBP2 NOP56 COPA GNE POLE POLR2C CGAS TTC27 CHCHD6 RFC5 ECH1 RLF NAMPT WDR11 MACF1 RPA1 ZNF281 KDM1A | 6.24e-11 | 1353 | 289 | 38 | 29467282 |
| Pubmed | Ankyrin-G induces nucleoporin Nup358 to associate with the axon initial segment of neurons. | 5.11e-10 | 13 | 289 | 6 | 31427429 | |
| Pubmed | 1.70e-08 | 11 | 289 | 5 | 17069463 | ||
| Pubmed | AHCYL1 ZBTB38 ZMYM2 TSC2 USP9Y LRP1B ZNF331 FBN1 PIAS3 SULF1 PKD1 MTMR3 BTG3 HERC2 ALDOA HECTD1 VWF ZNF473 COPA SYNE1 POLR2C APBB2 TTC27 APP TMEFF1 ZNF34 HEATR6 MACF1 ATM CABIN1 BECN1 ZNF292 | 3.88e-08 | 1285 | 289 | 32 | 35914814 | |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | KIAA0513 PPP2R2D NOC2L TUBB8 PER1 ZMYM2 ITGB1 TBC1D32 ANAPC1 A2ML1 EIF2S2 PKP1 PDS5A BRMS1 RANBP2 KAT5 COPA POLE NUP98 ECPAS TRIM3 ARL8B CABIN1 KDM1A XPO7 | 6.99e-08 | 857 | 289 | 25 | 25609649 |
| Pubmed | 1.07e-07 | 15 | 289 | 5 | 14697343 | ||
| Pubmed | 1.40e-07 | 71 | 289 | 8 | 33541421 | ||
| Pubmed | ZMYND11 PRSS8 SPINT1 ZFYVE16 ZMYM2 KEAP1 ZZEF1 ZNF518A PTPRC PIAS3 MCM3AP PKD1 HERC2 FHL2 VWF VPS8 RLF ZNF341 MACF1 TNPO3 | 1.47e-07 | 591 | 289 | 20 | 15231748 | |
| Pubmed | 1.60e-07 | 7 | 289 | 4 | 9037092 | ||
| Pubmed | 1.60e-07 | 7 | 289 | 4 | 24051001 | ||
| Pubmed | 1.60e-07 | 7 | 289 | 4 | 21205196 | ||
| Pubmed | 1.60e-07 | 7 | 289 | 4 | 24403063 | ||
| Pubmed | 1.60e-07 | 7 | 289 | 4 | 23536549 | ||
| Pubmed | 1.60e-07 | 7 | 289 | 4 | 12191015 | ||
| Pubmed | 1.60e-07 | 7 | 289 | 4 | 22821000 | ||
| Pubmed | Complex genomic rearrangements lead to novel primate gene function. | 1.60e-07 | 7 | 289 | 4 | 15710750 | |
| Pubmed | Genomic organization, expression, and localization of murine Ran-binding protein 2 (RanBP2) gene. | 1.60e-07 | 7 | 289 | 4 | 11353387 | |
| Pubmed | 1.60e-07 | 7 | 289 | 4 | 30944974 | ||
| Pubmed | 1.60e-07 | 7 | 289 | 4 | 38838144 | ||
| Pubmed | Retina-specifically expressed novel subtypes of bovine cyclophilin. | 1.60e-07 | 7 | 289 | 4 | 7559465 | |
| Pubmed | Mst1, RanBP2 and eIF4G are new markers for in vivo PI3K activation in murine and human prostate. | 1.60e-07 | 7 | 289 | 4 | 17372272 | |
| Pubmed | 1.60e-07 | 7 | 289 | 4 | 38657106 | ||
| Pubmed | 1.60e-07 | 7 | 289 | 4 | 18949001 | ||
| Pubmed | 1.60e-07 | 7 | 289 | 4 | 25187515 | ||
| Pubmed | 1.60e-07 | 7 | 289 | 4 | 8603673 | ||
| Pubmed | 1.60e-07 | 7 | 289 | 4 | 26632511 | ||
| Pubmed | 1.60e-07 | 7 | 289 | 4 | 23818861 | ||
| Pubmed | 1.60e-07 | 7 | 289 | 4 | 20682751 | ||
| Pubmed | The nucleoporin RanBP2 tethers the cAMP effector Epac1 and inhibits its catalytic activity. | 3.18e-07 | 8 | 289 | 4 | 21670213 | |
| Pubmed | 3.18e-07 | 8 | 289 | 4 | 27412403 | ||
| Pubmed | Mice lacking Ran binding protein 1 are viable and show male infertility. | 3.18e-07 | 8 | 289 | 4 | 21310149 | |
| Pubmed | The distribution of phosphorylated SR proteins and alternative splicing are regulated by RANBP2. | 3.18e-07 | 8 | 289 | 4 | 22262462 | |
| Pubmed | Zap70 and downstream RanBP2 are required for the exact timing of the meiotic cell cycle in oocytes. | 3.18e-07 | 8 | 289 | 4 | 28745977 | |
| Pubmed | RGPD4 AHCYL1 SPAG1 CLTCL1 MYLK NOC2L CFL1 RSF1 DGKA PTBP1 DDX1 RGPD3 CDNF ATP11A DNAH8 RGPD5 VIL1 RANBP2 RGPD8 NOP56 COPA PTBP2 SYNE1 NUP98 ARL8A AHCYL2 ARL8B CEP112 MACF1 ATM PLCH1 ZNF292 | 5.08e-07 | 1442 | 289 | 32 | 35575683 | |
| Pubmed | Genetic polymorphisms in 85 DNA repair genes and bladder cancer risk. | 5.21e-07 | 84 | 289 | 8 | 19237606 | |
| Pubmed | RGPD4 ZFYVE16 ZMYM2 ZNF217 KEAP1 ANAPC1 RGPD3 WDR62 RANBP2 RGPD8 USP24 TTC27 ECPAS RLF ZFHX3 KDM1A | 5.35e-07 | 418 | 289 | 16 | 34709266 | |
| Pubmed | 5.68e-07 | 3 | 289 | 3 | 24071006 | ||
| Pubmed | 5.68e-07 | 3 | 289 | 3 | 21088218 | ||
| Pubmed | ZNF281 contributes to the DNA damage response by controlling the expression of XRCC2 and XRCC4. | 5.68e-07 | 3 | 289 | 3 | 26300006 | |
| Pubmed | 5.69e-07 | 9 | 289 | 4 | 28100513 | ||
| Pubmed | 5.69e-07 | 9 | 289 | 4 | 17887960 | ||
| Pubmed | 5.69e-07 | 9 | 289 | 4 | 9733766 | ||
| Pubmed | Resolution of sister centromeres requires RanBP2-mediated SUMOylation of topoisomerase IIalpha. | 5.69e-07 | 9 | 289 | 4 | 18394993 | |
| Pubmed | 5.69e-07 | 9 | 289 | 4 | 11553612 | ||
| Pubmed | 5.69e-07 | 9 | 289 | 4 | 10601307 | ||
| Pubmed | 5.69e-07 | 9 | 289 | 4 | 28877029 | ||
| Pubmed | Peering through the pore: nuclear pore complex structure, assembly, and function. | 6.90e-07 | 38 | 289 | 6 | 12791264 | |
| Pubmed | Parkin ubiquitinates and promotes the degradation of RanBP2. | 9.43e-07 | 10 | 289 | 4 | 16332688 | |
| Pubmed | 9.43e-07 | 10 | 289 | 4 | 27160050 | ||
| Pubmed | Cyclophilin-related protein RanBP2 acts as chaperone for red/green opsin. | 9.43e-07 | 10 | 289 | 4 | 8857542 | |
| Pubmed | 9.43e-07 | 10 | 289 | 4 | 21859863 | ||
| Pubmed | Cloning and enzymatic analysis of 22 novel human ubiquitin-specific proteases. | 1.14e-06 | 23 | 289 | 5 | 14715245 | |
| Pubmed | TUBB8 CFL1 ACP1 KEAP1 PTBP1 DDX1 ANAPC1 EIF2B4 EIF2S2 UGDH FHL2 ALDOA NUP153 WDR62 NOP56 COPA ECPAS RFC5 CTSA WDR11 RPA1 KDM1A | 1.40e-06 | 809 | 289 | 22 | 32129710 | |
| Pubmed | 1.47e-06 | 11 | 289 | 4 | 34110283 | ||
| Pubmed | An Rtn4/Nogo-A-interacting micropeptide modulates synaptic plasticity with age. | 1.47e-06 | 11 | 289 | 4 | 35771867 | |
| Pubmed | ZMYND11 ACP1 RSF1 DDX1 TXNRD1 ANAPC1 EIF2S2 PDS5A NUP153 RANBP2 KAT5 COPA ATG7 POLE POLR2C NUP98 XRCC4 ECPAS RFC5 GTF2B NAMPT ATM RPA1 KDM1A XPO7 | 1.54e-06 | 1014 | 289 | 25 | 32416067 | |
| Pubmed | USP18 recruits USP20 to promote innate antiviral response through deubiquitinating STING/MITA. | 2.19e-06 | 12 | 289 | 4 | 27801882 | |
| Pubmed | 2.26e-06 | 4 | 289 | 3 | 23797810 | ||
| Pubmed | 2.26e-06 | 4 | 289 | 3 | 22174692 | ||
| Pubmed | Molecular mechanisms of retroviral integration site selection. | 2.26e-06 | 4 | 289 | 3 | 25147212 | |
| Pubmed | 2.26e-06 | 4 | 289 | 3 | 9480752 | ||
| Pubmed | 2.26e-06 | 4 | 289 | 3 | 11839768 | ||
| Pubmed | ZMYND11 ATXN7L1 RSF1 PER1 KEAP1 ZZEF1 ZNF829 ZNF518A SULF2 ANAPC1 PCDH19 MCM3AP ZDHHC13 VAV1 WDR62 ZNF574 KAT5 POLR2C TTC27 APP RFC5 ZNF711 MACF1 ZFHX3 ZNF281 KDM1A | 2.66e-06 | 1116 | 289 | 26 | 31753913 | |
| Pubmed | NOC2L RSF1 ANAPC1 MCM3AP PDS5A HERC2 HECTD1 NUP153 RANBP2 COPA POLE USP24 NUP98 ECPAS HELZ2 MACF1 ATM KDM1A XPO7 | 2.83e-06 | 653 | 289 | 19 | 22586326 | |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | MATN2 ACP1 ITGA6 TSC2 ZZEF1 ITGB1 LRP1B DDX1 SULF2 FBN1 TMEM131L ZDHHC13 HECTD1 TAP2 ADGRA3 WDR62 COPA SLITRK4 CRELD2 APP CTSA LYSMD3 TGFB1 TGFBI LIFR LTBP2 ATM | 3.28e-06 | 1201 | 289 | 27 | 35696571 |
| Pubmed | A direct physical interaction between Nanog and Sox2 regulates embryonic stem cell self-renewal. | 3.99e-06 | 146 | 289 | 9 | 23892456 | |
| Pubmed | A systems-wide screen identifies substrates of the SCFβTrCP ubiquitin ligase. | PER1 HECTD1 NUP153 WDR62 RANBP2 POLE APP NAMPT WDR11 PLCH1 ZNF281 | 4.40e-06 | 232 | 289 | 11 | 25515538 |
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | RGPD4 TRPC4AP PPP2R2D PER1 ZMYM2 ZNF331 ANAPC1 RGPD3 BTG3 PDS5A HERC2 FHL2 NUP153 WDR62 RGPD5 RANBP2 RGPD8 NOP56 COPA SYNE1 NUP98 TTC27 CHCHD6 CRY1 ATM KDM1A | 4.91e-06 | 1155 | 289 | 26 | 20360068 |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | DDX19B AHCYL1 TUBB8 CFL1 SEC24A PTBP1 ZZEF1 DDX1 TXNRD1 EIF2S2 UGDH FHL2 ALDOA HECTD1 COPA GNE ATG7 ZNRD2 POLR2C USP24 NUP98 ECPAS CTSA CERT1 OSBP NAMPT MACF1 RPA1 TNPO3 XPO7 | 5.11e-06 | 1455 | 289 | 30 | 22863883 |
| Pubmed | 5.61e-06 | 5 | 289 | 3 | 26109731 | ||
| Pubmed | A model for cofactor use during HIV-1 reverse transcription and nuclear entry. | 5.61e-06 | 5 | 289 | 3 | 24525292 | |
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | RGPD4 DDX19B CFL1 ACP1 TSC2 KEAP1 PTBP1 DDX1 MGAT2 ANAPC1 RGPD3 EIF2S2 ALDOA HECTD1 RGPD5 RANBP2 RGPD8 COPA POLE POLR2C TTC27 RFC5 NAMPT WDR11 NUB1 RPA1 KDM1A | 7.51e-06 | 1257 | 289 | 27 | 37317656 |
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | AHCYL1 TRPC4AP PPP2R2D ZFYVE16 ACP1 MPDZ ITGB1 EIF2B4 EIF2S2 UGDH MTMR3 TMEM131L FHL2 HECTD1 NUP153 RANBP2 POLE NUP98 TTC27 ECPAS TNPO3 SNTB1 KDM1A | 8.25e-06 | 974 | 289 | 23 | 28675297 |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | TUBB8 CFL1 SEC24A ACP1 TSC2 PTBP1 ITGB1 DDX1 TXNRD1 EIF2B4 EIF2S2 PKP1 PDS5A FHL2 ALDOA HECTD1 SPINK5 RANBP2 NOP56 COPA POLR2C USP24 TTC27 AHCYL2 RFC5 ECH1 GTF2B NAMPT MACF1 | 8.30e-06 | 1415 | 289 | 29 | 28515276 |
| Pubmed | PRSS8 NOC2L TUBB8 ZMYM2 MPDZ ZNF217 ANAPC1 RGPD3 EIF2S2 PDS5A HERC2 FHL2 ZNF574 RANBP2 KAT5 ZNRD2 SYNE1 POLR2C FAM76B APP RFC5 PLPP2 WDR11 ZNF277 HELZ2 MACF1 ZFHX3 ZNF281 EDRF1 KDM1A | 8.87e-06 | 1497 | 289 | 30 | 31527615 | |
| Pubmed | Interaction network of human early embryonic transcription factors. | AHCYL1 ZMYM2 ZNF217 PCGF3 MCM3AP RANBP2 KAT5 NUP98 APP RLF ZFHX3 ZNF281 KDM1A | 8.92e-06 | 351 | 289 | 13 | 38297188 |
| Pubmed | KIAA0513 ZFYVE16 USP31 UNC5A PCDH19 MCM3AP MTMR3 KIF17 APPBP2 SYNE1 VPS8 AHCYL2 MACF1 XPO7 | 9.33e-06 | 407 | 289 | 14 | 12693553 | |
| Pubmed | The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery. | ZMYND11 NOC2L RSF1 ZMYM2 ITGA6 PTBP1 ITGB1 ZNF518A MGAT2 PIAS3 ANAPC1 PDS5A ALDOA USP3 TAP2 ZNF574 RANBP2 ZNF473 FAM76B ZNF711 RLF ARL8B CD40 ZNF281 TNPO3 XPO7 | 1.00e-05 | 1203 | 289 | 26 | 29180619 |
| Pubmed | TRIM75 NOC2L RSF1 HELB PDS5A FHL2 BRMS1 RANBP2 NOP56 POLE NUP98 ZFPM2 METTL6 ZMAT3 ZNF281 | 1.06e-05 | 469 | 289 | 15 | 27634302 | |
| Pubmed | 1.11e-05 | 6 | 289 | 3 | 21217818 | ||
| Pubmed | 1.11e-05 | 6 | 289 | 3 | 9686317 | ||
| Pubmed | 1.11e-05 | 6 | 289 | 3 | 19182256 | ||
| Pubmed | The deubiquitinase TRABID stabilizes the K29/K48-specific E3 ubiquitin ligase HECTD1. | 1.25e-05 | 212 | 289 | 10 | 33853758 | |
| Pubmed | DDX19B KEAP1 PIK3C2B HERC2 HECTD1 USP3 APPBP2 ZNRD2 POLR2C USP24 CHCHD6 MACF1 NUB1 ZNF281 CAPN15 | 1.43e-05 | 481 | 289 | 15 | 28190767 | |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | LCA5L DGKA TSC2 ZZEF1 SSPOP MCM3AP PKD1 PDS5A MROH9 VIL1 CACNA1F APPBP2 GFRAL MUC19 ECPAS LOXHD1 ATM RPA1 FBN3 | 1.53e-05 | 736 | 289 | 19 | 29676528 |
| Pubmed | SPINT1 NOC2L CFL1 MATN2 PTBP1 SSPOP BTG3 CACNA1G FHL2 KIF17 TRIB2 PTBP2 XRCC4 ZFPM2 ZNF277 BECN1 ZNF639 | 1.58e-05 | 608 | 289 | 17 | 16713569 | |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | ZMYND11 RSF1 ZMYM2 PDS5A HERC2 USP3 ZNF567 PTBP2 ZNF570 RFC5 ZNF711 RLF CABIN1 RPA1 ZNF281 KDM1A ZNF292 | 1.58e-05 | 608 | 289 | 17 | 36089195 |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | CLTCL1 PPP2R2D CFL1 PTBP1 ZZEF1 DDX1 TXNRD1 EIF2S2 CACNA1G ALDOA NOP56 COPA SYNE1 MUC19 ECPAS ECH1 NAMPT ARL8B MACF1 ZFHX3 | 1.64e-05 | 807 | 289 | 20 | 30575818 |
| Pubmed | 1.64e-05 | 19 | 289 | 4 | 32582689 | ||
| Pubmed | The human immunodeficiency virus transactivator Tat interacts with the RNA polymerase II holoenzyme. | 1.75e-05 | 39 | 289 | 5 | 9121429 | |
| Pubmed | DDX19B CLTCL1 CFL1 DGKA PTBP1 ITGB1 DDX1 MGAT2 PTPRC GBP5 ATP11A HERC2 ALDOA ZDHHC13 TAP2 RANBP2 NOP56 COPA ARL8A ECPAS ECH1 CTSA WDR11 ARL8B HELZ2 | 1.76e-05 | 1168 | 289 | 25 | 19946888 | |
| Pubmed | 1.94e-05 | 7 | 289 | 3 | 10848613 | ||
| Pubmed | Autophagy protects the retina from light-induced degeneration. | 1.94e-05 | 7 | 289 | 3 | 23341467 | |
| Pubmed | Disrupting circadian homeostasis of sympathetic signaling promotes tumor development in mice. | 1.94e-05 | 7 | 289 | 3 | 20539819 | |
| Pubmed | HSF1 transcriptional activity is modulated by IER5 and PP2A/B55. | 1.94e-05 | 7 | 289 | 3 | 25816751 | |
| Pubmed | 1.94e-05 | 7 | 289 | 3 | 12900400 | ||
| Pubmed | Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms. | KEAP1 ITGB1 TXNRD1 FBN1 MTMR3 HERC2 FHL2 HECTD1 NUP153 APPBP2 ZNRD2 NUP98 TTC27 ECPAS TRIM3 HEATR6 WDR11 CEP112 TNPO3 | 2.13e-05 | 754 | 289 | 19 | 33060197 |
| Pubmed | RGPD4 CFL1 ZMYM2 MPDZ TSC2 KEAP1 ANAPC1 RGPD3 KCNMA1 HERC2 NUP153 RANBP2 RGPD8 NOP56 ZNRD2 SYNE1 TRIM3 P2RX7 MACF1 CABIN1 RPA1 KDM1A | 2.15e-05 | 963 | 289 | 22 | 28671696 | |
| Pubmed | Proteomic and yeast 2-hybrid screens to identify PTEN binding partners. | 2.18e-05 | 226 | 289 | 10 | 37839992 | |
| Interaction | IER2 interactions | 7.01e-07 | 37 | 282 | 7 | int:IER2 | |
| Interaction | ZSCAN21 interactions | CLTCL1 ZMYM2 LRP1B NOP56 ZNF473 ARL8A APP AR ZNF710 LTBP2 ZMYM6 | 1.90e-06 | 128 | 282 | 11 | int:ZSCAN21 |
| Interaction | RGPD4 interactions | 1.12e-05 | 22 | 282 | 5 | int:RGPD4 | |
| Cytoband | 20q12-q13.2 | 1.18e-04 | 3 | 289 | 2 | 20q12-q13.2 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | ZBTB38 ZBTB20 ZNF391 ZBTB8B ZNF217 ZNF225 ZNF829 ZNF518A ZNF331 ZNF506 ZNF574 ZNF567 ZNF473 ZNF570 ZNF883 ZIM3 ZFPM2 ZNF248 ZNF404 ZNF710 ZNF711 RLF ZNF34 OVOL1 ZNF341 ZNF665 ZFHX3 ZNF333 ZNF281 ZNF415 ZNF639 ZNF292 | 1.43e-10 | 718 | 217 | 32 | 28 |
| GeneFamily | Ubiquitin specific peptidases | 4.59e-06 | 56 | 217 | 7 | 366 | |
| GeneFamily | Tetratricopeptide repeat domain containing|Bardet-Biedl syndrome associated|BBSome | 7.45e-05 | 115 | 217 | 8 | 769 | |
| GeneFamily | Nucleoporins | 5.58e-04 | 32 | 217 | 4 | 1051 | |
| GeneFamily | WD repeat domain containing|Protein phosphatase 2 regulatory subunits | 6.97e-04 | 15 | 217 | 3 | 696 | |
| GeneFamily | Zinc fingers RANBP2-type |RNA binding motif containing | 1.93e-03 | 21 | 217 | 3 | 89 | |
| GeneFamily | Zinc fingers MYM-type | 2.08e-03 | 6 | 217 | 2 | 86 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | ZMYND11 ZBTB20 ZFYVE16 SEC24A ZMYM2 ITGA6 ATP8B1 ZZEF1 TXNRD1 RIN2 MTMR3 TMEM131L PDS5A NUP153 ADGRA3 RANBP2 APPBP2 GNE USP24 NUP98 APBB2 XRCC4 APP CRY1 RLF NAMPT MACF1 ZFHX3 ZNF292 | 7.86e-08 | 856 | 286 | 29 | M4500 |
| Coexpression | RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN | ZBTB20 MYLK MYO9A MATN2 RSF1 ZMYM2 RNF217 ZNF518A ZNF331 TBC1D32 FBN1 PTPRG MTMR3 ZNF506 HECTD1 APBB2 AHCYL2 XRCC2 WDPCP LIFR NAMPT WDR11 ZFHX3 LTBP2 CABIN1 EPCAM SNTB1 XPO7 | 8.18e-08 | 807 | 286 | 28 | M16651 |
| Coexpression | GRYDER_PAX3FOXO1_ENHANCERS_IN_TADS | RGPD4 ZFYVE16 MYO9A KBTBD8 ZNF217 ZZEF1 ITGB1 TNFRSF21 DDX1 HELB ZNF331 TXNRD1 SULF2 KCNMA1 PKP1 TMEM131L KCNS3 HERC2 COPA APBB2 APP RFC5 PKNOX2 RANBP17 WDR11 ARL8B CEP112 SNTB1 XPO7 | 2.25e-06 | 1009 | 286 | 29 | M157 |
| Coexpression | PATEL_SKIN_OF_BODY_ZOSTAVAX_AGE_70_93YO_VZV_CHALLENGE_6HR_UP | SEC24A ZNF217 MGAT2 PTPRC SULF1 UGDH ATP11A ZNF567 GPR65 FAM76B ECPAS CRY1 LIFR NAMPT | 4.35e-06 | 291 | 286 | 14 | M41002 |
| Coexpression | NABA_ECM_GLYCOPROTEINS | MATN2 SSPOP NTNG2 FBN1 OTOGL VWF CRELD2 TECTA TGFBI EGFLAM LTBP2 | 8.76e-06 | 191 | 286 | 11 | MM17059 |
| Coexpression | NABA_ECM_GLYCOPROTEINS | MATN2 SSPOP NTNG2 FBN1 VWF CRELD2 TECTA TGFBI EGFLAM LTBP2 FBN3 | 1.12e-05 | 196 | 286 | 11 | M3008 |
| Coexpression | SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4 | PER1 PIAS3 BTG3 KCNS3 ADGRF5 ATP11A SYNE1 AHCYL2 RANBP17 CEP112 TLE2 | 1.17e-05 | 197 | 286 | 11 | M12824 |
| Coexpression | GAUSSMANN_MLL_AF4_FUSION_TARGETS_B_UP | 2.76e-05 | 33 | 286 | 5 | MM477 | |
| Coexpression | GRYDER_PAX3FOXO1_TOP_ENHANCERS | ZNF217 ZZEF1 ITGB1 DDX1 HELB ZNF331 TXNRD1 SULF2 PKP1 TMEM131L KCNS3 COPA APBB2 APP PKNOX2 SNTB1 | 3.13e-05 | 441 | 286 | 16 | M172 |
| Coexpression | GENTILE_UV_RESPONSE_CLUSTER_D2 | 5.58e-05 | 38 | 286 | 5 | M12861 | |
| Coexpression | GOZGIT_ESR1_TARGETS_DN | PRSS8 KIAA0513 ITGA6 MPDZ TRANK1 PIAS3 PTPRG SULF1 UGDH ZNF506 VIL1 TRIB2 APBB2 AHCYL2 AR TNFRSF11B TGFBI MACF1 LTBP2 GREB1 PLCH1 DIRAS2 | 5.83e-05 | 786 | 286 | 22 | M10961 |
| Coexpression | GSE3982_BCELL_VS_NKCELL_DN | 6.56e-05 | 197 | 286 | 10 | M5548 | |
| Coexpression | CUI_TCF21_TARGETS_2_DN | ZBTB38 ZFYVE16 ATXN7L1 ATP8B1 ITGB1 ZNF518A SULF2 PTPRC PTPRG RIN2 ADAMTS16 ADGRF5 TRIB2 APBB2 APP ECPAS LYSMD3 TNFRSF11B LIFR ARL8B LMX1B MACF1 SNTB1 | 7.08e-05 | 854 | 286 | 23 | M1533 |
| Coexpression | GSE3982_EOSINOPHIL_VS_MAST_CELL_UP | ZNF217 TMEM131L MROH9 CACNA1F GPR65 APBB2 TNFRSF11B GTF2B ZNF281 ZNF292 | 7.14e-05 | 199 | 286 | 10 | M5397 |
| Coexpression | GSE1432_CTRL_VS_IFNG_24H_MICROGLIA_UP | ZMYND11 DGKA TNFRSF21 RHOBTB1 SULF1 ZNF710 CRB1 ZFHX3 LTBP2 RPA1 | 7.44e-05 | 200 | 286 | 10 | M3407 |
| Coexpression | GSE17721_CTRL_VS_CPG_4H_BMDC_UP | 7.44e-05 | 200 | 286 | 10 | M3761 | |
| Coexpression | GSE34515_CD16_POS_MONOCYTE_VS_DC_UP | 7.44e-05 | 200 | 286 | 10 | M8765 | |
| Coexpression | GABRIELY_MIR21_TARGETS | ZBTB38 ZBTB20 MYO9A RSF1 ZMYM2 MPDZ HECTD1 TPRG1L GNE LIFR ANO3 ZNF292 | 8.75e-05 | 289 | 286 | 12 | M2196 |
| Coexpression | NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_3DY_DN | PER1 DGKA ANAPC1 BTG3 USP3 NUP153 RGPD5 RANBP2 RGPD8 COPA GNE PTBP2 GTF2B OSBP ZNF639 | 9.02e-05 | 432 | 286 | 15 | M41149 |
| Coexpression | TABULA_MURIS_SENIS_TRACHEA_GRANULOCYTE_AGEING | 1.02e-04 | 43 | 286 | 5 | MM3857 | |
| Coexpression | WANG_SMARCE1_TARGETS_UP | MYLK MATN2 ATP8B1 SULF2 SULF1 FHL2 TRIB2 DIRAS1 TGFB1 ZNF711 TGFBI LIFR | 1.03e-04 | 294 | 286 | 12 | M1804 |
| Coexpression | CUI_TCF21_TARGETS_2_DN | ZBTB38 ZFYVE16 ATXN7L1 ATP8B1 ITGB1 ZNF518A SULF2 PTPRC PTPRG RIN2 ADAMTS16 ADGRF5 TRIB2 APBB2 APP ECPAS LYSMD3 TNFRSF11B LIFR ARL8B LMX1B MACF1 SNTB1 | 1.26e-04 | 888 | 286 | 23 | MM1018 |
| Coexpression | BLANCO_MELO_BRONCHIAL_EPITHELIAL_CELLS_INFLUENZA_A_INFECTION_UP | 1.35e-04 | 137 | 286 | 8 | M34024 | |
| Coexpression | LAKE_ADULT_KIDNEY_C22_ENDOTHELIAL_CELLS_GLOMERULAR_CAPILLARIES | 1.35e-04 | 137 | 286 | 8 | M39241 | |
| Coexpression | WONG_ADULT_TISSUE_STEM_MODULE | ZMYND11 ZBTB20 MYLK MATN2 PER1 DGKA MPDZ UGDH KCNMA1 BTG3 ADGRA3 VWF GPR65 APP LYSMD3 TNFRSF11B CD40 MACF1 LTBP2 ZMYM6 | 1.43e-04 | 721 | 286 | 20 | M1999 |
| Coexpression | DIAZ_CHRONIC_MYELOGENOUS_LEUKEMIA_UP | AHCYL1 ZMYND11 MATN2 ACP1 TSC2 ZNF217 KEAP1 PTBP1 DDX1 TXNRD1 PTPRC PLA2G12A ANAPC1 EIF2S2 FHL2 NUP153 RANBP2 COPA POLR2C NUP98 CRY1 TGFB1 GTF2B NAMPT WDR11 ZNF277 RPA1 BECN1 ZNF281 TNPO3 CAPN15 | 1.52e-04 | 1399 | 286 | 31 | M535 |
| Coexpression | GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_UP | PRSS8 SPINT1 DGKA ITGA6 TNFRSF21 MGAT2 PIAS3 PLA2G12A RIN2 PKP1 BTG3 POLK FHL2 KIF17 TTC27 CRELD2 AHCYL2 METTL6 ZMAT3 GTF2B OVOL1 CEP112 HELZ2 NUB1 LTBP2 BECN1 ZNF281 | 1.68e-04 | 1151 | 286 | 27 | M1103 |
| Coexpression | BUSSLINGER_GASTRIC_ISTHMUS_CELLS | CFL1 ITGA6 ATP8B1 PTBP1 ITGB1 TXNRD1 EIF2S2 UGDH PLA2G10 CAPN5 FHL2 SPINK5 NOP56 CRELD2 EPCAM | 1.71e-04 | 458 | 286 | 15 | M40010 |
| ToppCell | droplet-Kidney-KIDNEY-30m-Epithelial-collecting_duct_principal_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | RNF217 UNC5A PCDH19 CAPN5 ELMOD1 WDR62 CACNA1D SLITRK4 ZNF711 TMEFF1 PPP2R2C | 2.93e-08 | 181 | 288 | 11 | 7af469f5bcb9b1ab3f35b2758bf2afb87e8eba57 |
| ToppCell | CV-Healthy-7|CV / Virus stimulation, Condition and Cluster | DDX19B ZNF829 PLA2G12A TMEM131L ATP11A RGPD8 OSBP P2RX7 WDR11 RNF122 ZMYM6 | 3.47e-08 | 184 | 288 | 11 | 0e5cc77aaa73ceb791f8be7456177577fd2e5586 |
| ToppCell | CV-Healthy-7|Healthy / Virus stimulation, Condition and Cluster | DDX19B ZNF829 PLA2G12A TMEM131L ATP11A RGPD8 OSBP P2RX7 WDR11 RNF122 ZMYM6 | 3.67e-08 | 185 | 288 | 11 | 1979d189c204f4c2893e3170a514ee7d5523406c |
| ToppCell | mild-low-quality_cells|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | ZBTB20 DGKA USP9Y HELB TBC1D32 RGPD5 SYNE1 RTTN PPP2R2B ATM ZNF292 | 6.98e-08 | 197 | 288 | 11 | e4331969bd911d1ebb5453f40a7057297b5389b4 |
| ToppCell | 10x5'-blood-Lymphocytic_T_CD4-T_CD4/CD8|blood / Manually curated celltypes from each tissue | ZBTB20 DGKA USP9Y HELB PTPRC ZNF506 TMEM131L RANBP2 MACF1 ATM | 1.09e-07 | 162 | 288 | 10 | b4535bcb3f469bc139e73f1122f4070013e5a1de |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | MYO7B SSPOP LRP1B TRANK1 OTOGL ADAMTS16 CACNA1F LOXHD1 PLCH1 ANO3 | 3.55e-07 | 184 | 288 | 10 | 2cbed6462fea2622871bb7e49b0df3d984239281 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | MYO7B SSPOP LRP1B TRANK1 OTOGL ADAMTS16 CACNA1F LOXHD1 PLCH1 ANO3 | 3.55e-07 | 184 | 288 | 10 | 2b19a8c5f823e00812908b23e66bb4e563278aff |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | MYO7B SSPOP LRP1B TRANK1 OTOGL ADAMTS16 CACNA1F LOXHD1 PLCH1 ANO3 | 3.55e-07 | 184 | 288 | 10 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 |
| ToppCell | facs-Heart-Unknown-3m-Endothelial-endothelial_cell_of_coronary_artery|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.56e-07 | 141 | 288 | 9 | 4aa4b3476dc5abefbd348353cfe711cd5fe3d52f | |
| ToppCell | facs-Heart-Unknown-3m-Endothelial-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.56e-07 | 141 | 288 | 9 | e40c6f1b7fbaa46b3eaa55f1b37ef360b04370a8 | |
| ToppCell | facs-Heart-Unknown-3m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.78e-07 | 142 | 288 | 9 | 759fbbd15b4fb313bd6269b7f087edafebd530ef | |
| ToppCell | Control-Fibroblasts-Alveolar_FB|Control / group, cell type (main and fine annotations) | MYLK FBN1 PTPRG CACNA1D ADAMTSL3 ZFPM2 PKNOX2 MACF1 LTBP2 ANO3 | 4.12e-07 | 187 | 288 | 10 | 92d468dde81125d51daf7abd4703741abe1ab91c |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | MYLK FBN1 PTPRG CACNA1D ADAMTSL3 ZFPM2 PKNOX2 MACF1 LTBP2 ANO3 | 5.00e-07 | 191 | 288 | 10 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 |
| ToppCell | RA-09._Endothelium_I|World / Chamber and Cluster_Paper | 5.00e-07 | 191 | 288 | 10 | c8a0c2af119bc34a8f694a7d30642f28002c84b9 | |
| ToppCell | RA-09._Endothelium_I|RA / Chamber and Cluster_Paper | 5.25e-07 | 192 | 288 | 10 | 8a1b1c3e83a68ad74f8f4eb00455c9e41aa57cfc | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | MYLK FBN1 PTPRG CACNA1D ADAMTSL3 ZFPM2 PKNOX2 MACF1 LTBP2 ANO3 | 5.25e-07 | 192 | 288 | 10 | 99ce9e3c4c50cf64ebb62145f2b5420efa0db309 |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 7.28e-07 | 199 | 288 | 10 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.03e-06 | 160 | 288 | 9 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.03e-06 | 160 | 288 | 9 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_NK-T_mait|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 2.27e-06 | 176 | 288 | 9 | 003076f1a983409ddf31b9c19e61c1facdd72566 | |
| ToppCell | wk_20-22-Epithelial-Proximal_epithelial-basal_late|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 2.50e-06 | 178 | 288 | 9 | 03f22485074b3cbf9a6ad4d543c5bbfa826dc741 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.3|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.61e-06 | 179 | 288 | 9 | 2b5f8e109a67c7fc3ec2b83e8f1854160c99283a | |
| ToppCell | COPD-Endothelial-VE_Venous|Endothelial / Disease state, Lineage and Cell class | 2.61e-06 | 179 | 288 | 9 | e816dd846a6918ec143b57a380c3a47ed073b66e | |
| ToppCell | E18.5-samps-Mesenchymal-Myofibroblast|E18.5-samps / Age Group, Lineage, Cell class and subclass | 3.13e-06 | 183 | 288 | 9 | de08f9ea02b7244d5a8788064631d10f06565337 | |
| ToppCell | Control-Fibroblasts|Control / group, cell type (main and fine annotations) | 4.26e-06 | 190 | 288 | 9 | 3a42a9b98d954685d38a741f44545898d0e3e9ce | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 4.63e-06 | 192 | 288 | 9 | 47646d7e4990be85072987f92bf18d52f8da752e | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature4_(1)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 4.63e-06 | 192 | 288 | 9 | 6bba80887d6f64cf913a5c22f62baaddda417ce0 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature4_(1)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 4.83e-06 | 193 | 288 | 9 | dbf0fe496254320c894568c31e5f9ce63707d1b5 | |
| ToppCell | E15.5-Mesenchymal-myocytic_cell-aortic_smooth_muscle_cell|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.83e-06 | 193 | 288 | 9 | e787e618f6e8a1e22be366ce606bf78831b60a90 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-3m-Epithelial-luminal_progenitor_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.04e-06 | 194 | 288 | 9 | 550e61a40be2baa59520aaf5912bb99ad094ba15 | |
| ToppCell | RV-09._Endothelium_I|RV / Chamber and Cluster_Paper | 5.04e-06 | 194 | 288 | 9 | 7b408096e717f2327c12aea35a8d5fc4621d3b06 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Gen_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.04e-06 | 194 | 288 | 9 | 0b9cd96fa0b616da7cc90e92ff71157e9bba518f | |
| ToppCell | LA-08._Macrophage|LA / Chamber and Cluster_Paper | 5.26e-06 | 195 | 288 | 9 | 5e1d5bdb8874091f5a2b1d0a8cc9008165718a97 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.48e-06 | 196 | 288 | 9 | 7d8505dac15fa59935ccf592afc54b04c4c6554f | |
| ToppCell | COVID_non-vent-Lymphocytic|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 5.71e-06 | 197 | 288 | 9 | c672915f8c8c1e948d251f6eaf9f84a5600c1193 | |
| ToppCell | TCGA-Skin-Metastatic-Melanoma|TCGA-Skin / Sample_Type by Project: Shred V9 | 5.95e-06 | 198 | 288 | 9 | af4fb9eb2295c7b90624b38ba25619aa15254efa | |
| ToppCell | TCGA-Skin-Metastatic|TCGA-Skin / Sample_Type by Project: Shred V9 | 5.95e-06 | 198 | 288 | 9 | ad39cce004867f083f8da1954e0cf5a263815184 | |
| ToppCell | TCGA-Skin-Metastatic-Melanoma-Skin_Cutaneous_Melanoma|TCGA-Skin / Sample_Type by Project: Shred V9 | 5.95e-06 | 198 | 288 | 9 | 62cbf4b29e8af4983fb47a17f96da62682a5137e | |
| ToppCell | nucseq-Mesenchymal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.95e-06 | 198 | 288 | 9 | 8f52243ca8b9ba68a75ae411506a3a6de258eb97 | |
| ToppCell | moderate-Myeloid-Non-resident_Macrophage|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 6.19e-06 | 199 | 288 | 9 | 3895e367a33ac0316f96a64c07574de99684f4b7 | |
| ToppCell | Control_saline|World / Treatment groups by lineage, cell group, cell type | 6.19e-06 | 199 | 288 | 9 | 11c9c1779caceb725ecccf3f23b7d4e6dbd1af64 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.19e-06 | 199 | 288 | 9 | 2e7f517c0444b4f29ff11c26ab32e9cc0f7e99ef | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 6.45e-06 | 200 | 288 | 9 | 032df80aa5c40991e1c1e80f9d8da106e6aeaee2 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Activated_Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 6.45e-06 | 200 | 288 | 9 | 2d07237022b409c4fac6fcf99b68c8affb3007cd | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN---|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 6.45e-06 | 200 | 288 | 9 | 68fce28690246895fd33354b30960ebcc31aa4cc | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN----L2-6|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 6.45e-06 | 200 | 288 | 9 | 878bbbe32e3602723aa14ef32877ab2453b8c6e5 | |
| ToppCell | 5'-Adult-LargeIntestine-Epithelial-mature_enterocytic-Colonocyte|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.45e-06 | 200 | 288 | 9 | b2fa6e44ace5897766792ed97ffafc11555175e7 | |
| ToppCell | metastatic_Lymph_Node-Epithelial_cells-Malignant_cells|metastatic_Lymph_Node / Location, Cell class and cell subclass | 6.45e-06 | 200 | 288 | 9 | 5e2def2e56f21bc7295cdcf3580f5c0d16a6a494 | |
| ToppCell | mild-CD8+_Tem|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 6.45e-06 | 200 | 288 | 9 | d8aec4904c9420b8f9d7508658ba1e36c66cdfcc | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN-|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 6.45e-06 | 200 | 288 | 9 | 376b19ab5a7cd2c85f726d8ba41337d4525863e5 | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN--|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 6.45e-06 | 200 | 288 | 9 | 7fa54370221ed61bac0e09e6bcf1f3dff202a846 | |
| ToppCell | 5'-Adult-LargeIntestine-Epithelial-mature_enterocytic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.45e-06 | 200 | 288 | 9 | 3f29823952a4303451997dd5177a51179bd20540 | |
| ToppCell | Hematolymphoid-Endothelial|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 6.45e-06 | 200 | 288 | 9 | 7136936d05ab344a560cf159684c881063b5430d | |
| ToppCell | CV-Healthy-3|CV / Virus stimulation, Condition and Cluster | 1.03e-05 | 161 | 288 | 8 | fd4a79385ea967b9900dc76a3add813b894a3a28 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2-Exc_L3-5_RORB_CMAHP|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.40e-05 | 168 | 288 | 8 | 1d58731a481ecac84c15affa84f8041dd67d944c | |
| ToppCell | Ionocyte-iono-1|World / Class top | 1.47e-05 | 169 | 288 | 8 | 4b68bcb4b5fc3cd2db23cd4edace7444aa2d605c | |
| ToppCell | E17.5-Mesenchymal-developing_mesenchymal_cell-mesenchymal_immature_unknown_1|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.53e-05 | 170 | 288 | 8 | 7fa022471e14ac8a3bc147c793368a4d56a8e591 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2-Exc_L3-5_RORB_CMAHP|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.60e-05 | 171 | 288 | 8 | 9d5cabd71a901a00eb16c4d151189296f1b3bf6f | |
| ToppCell | Nasal_Brush-Epithelial-Ionocytes|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.66e-05 | 172 | 288 | 8 | 04fabb40fa9357d8902f3b04adc15231626cd9f8 | |
| ToppCell | Nasal_Brush-Epithelial-Ionocytes|Nasal_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.66e-05 | 172 | 288 | 8 | dd3a23dc78dc6939f41126f8d7bd23a2e4713647 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Epithelial-Epcam____podocyte-3|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.81e-05 | 174 | 288 | 8 | 76310c0af1d7df6a4de3816838b2ac2892f68746 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_NK-T_mait-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.89e-05 | 175 | 288 | 8 | cc2428150987911d0d382e8177918724aa69f85c | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2-Exc_L3-5_RORB_CMAHP|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.89e-05 | 175 | 288 | 8 | d4827b4dfad07f11cbdd47fbed287af1afb9b1b8 | |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.96e-05 | 176 | 288 | 8 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_prolif|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.05e-05 | 177 | 288 | 8 | 30f82b04e48940bfcaf2c22677efe6d57ae3f1a7 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.13e-05 | 178 | 288 | 8 | 01dafd19de04eff459253eaa9a35debf8f3deedf | |
| ToppCell | B_cells-Naive_B_cells_|B_cells / Immune cells in Kidney/Urine in Lupus Nephritis | 2.13e-05 | 178 | 288 | 8 | 71ac2eca5cf13a91f86b80690748b0788392dcfc | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.13e-05 | 178 | 288 | 8 | 0e1bedf991189d0ef9b40dac9281bdf4739333a1 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.22e-05 | 179 | 288 | 8 | 8766a5a066091879f521acfc612abf563ff78808 | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-pericyte_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | TNFRSF21 PCDH19 GPRC6A TMEM30CP ADAMTSL3 TNFRSF11B EGFLAM LTBP2 | 2.22e-05 | 179 | 288 | 8 | d4a975d8ffa5e77fb5c0ec05bf9c8f843c77ce07 |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-Pericyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | TNFRSF21 PCDH19 GPRC6A TMEM30CP ADAMTSL3 TNFRSF11B EGFLAM LTBP2 | 2.22e-05 | 179 | 288 | 8 | 7078022e60faa86444f2a2c6eb9f767cc66b5cfa |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Mesenchymal-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.40e-05 | 181 | 288 | 8 | 709e9c7a60d5f98635b99895ce30bb87a9f7376d | |
| ToppCell | droplet-Lung-1m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l25|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.40e-05 | 181 | 288 | 8 | 136b0c60680068838d184d32aa99d7bea8718dbc | |
| ToppCell | COVID-19-Heart-Fib_+_EC_+_Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.50e-05 | 182 | 288 | 8 | fbd5e332df73bf7141c822fa67b76367dc962017 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Intercalated_Cell_Type_B|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.96e-05 | 136 | 288 | 7 | 7cd22169fb71c6caf9feb203ad98be8480a54fba | |
| ToppCell | TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Infiltrating_Ductal_Carcinoma-6|TCGA-Breast / Sample_Type by Project: Shred V9 | 3.03e-05 | 187 | 288 | 8 | a96495803ba13fcfadd1d83b3cf5774f3fed0a20 | |
| ToppCell | ILEUM-inflamed-(3)_MNP-(3)_moDC|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 3.03e-05 | 187 | 288 | 8 | 0099def970fbc828756fbf853eca2ce77b8cd342 | |
| ToppCell | 10x3'2.3-week_12-13-Lymphocytic_NK-T_NK-ILC_precursor|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 3.03e-05 | 187 | 288 | 8 | f31d865ce2a21bdf64dbe29ee3e4505ab482604a | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 3.15e-05 | 188 | 288 | 8 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | facs-MAT-Fat-3m|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.15e-05 | 188 | 288 | 8 | 7da9750255efbc5cf9aed7e3105a337fac63b9f0 | |
| ToppCell | (1)_Control_(PBS)-(3)_LEPR+_perivascular_cells|World / Stress and Cell class | 3.40e-05 | 190 | 288 | 8 | ec0ab31266583a0966ac7615d5c0fabb7b7e66e8 | |
| ToppCell | PND10|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.40e-05 | 190 | 288 | 8 | d67e2814047c8df2ae4b7bc8be9539f5df6ecef2 | |
| ToppCell | 3'_v3-blood-Lymphocytic_T_CD8-Tem/emra_CD8|blood / Manually curated celltypes from each tissue | 3.40e-05 | 190 | 288 | 8 | 5624f711b34132081f93fa70702316962e3e3c64 | |
| ToppCell | LV-02._Fibroblast_II|World / Chamber and Cluster_Paper | 3.53e-05 | 191 | 288 | 8 | d36565257ccba8c1bbed2c1c01be66a9cbb5f834 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25|PBMC_fresh-frozen / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.53e-05 | 191 | 288 | 8 | 1ecd9849d14d5ebf3daf610e83fb50820cafd3ed | |
| ToppCell | ILEUM-non-inflamed-(1)_Tregs|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 3.53e-05 | 191 | 288 | 8 | e065d16a1f88c91dec576d248a318534ceab1cb2 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.66e-05 | 192 | 288 | 8 | 5105e4b577408b4e1a62d0a44c23c2b830ccad88 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_neuroendo-epi_NE_progenitor_(7)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 3.66e-05 | 192 | 288 | 8 | b99f8236ef4ccdc75c02abea381cae6453205f6f | |
| ToppCell | NS-moderate-d_16-33-Epithelial-Squamous|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.66e-05 | 192 | 288 | 8 | 103496f428f59683ac3ae6147682c07c30663724 | |
| ToppCell | facs-Aorta-Heart-3m|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.66e-05 | 192 | 288 | 8 | 1ccc47792edf9ee23501c8e2165d11271636b66a | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 3.80e-05 | 193 | 288 | 8 | fce4f805e53669acb4c188f87ac7d84408c0c218 | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 3.80e-05 | 193 | 288 | 8 | 6e1498153a7766c03fddbda1701dbf1596d21736 | |
| ToppCell | RV-09._Endothelium_I|World / Chamber and Cluster_Paper | 3.80e-05 | 193 | 288 | 8 | e3fa47e2c7cd8a5b69186711c57751f2296de8ae | |
| ToppCell | E15.5-Mesenchymal-myocytic_cell|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.80e-05 | 193 | 288 | 8 | 3316d6a39abb6a518d45b846254325fc7a8b2035 | |
| ToppCell | Megakaryocytic-erythropoietic-Megakaryo-cells-Platelet|Megakaryocytic-erythropoietic / Lineage, cell class and subclass | 3.80e-05 | 193 | 288 | 8 | 06ddaeb2fd32895181e23f3f1bb3e9103e79752c | |
| ToppCell | severe-low-quality_cells|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.80e-05 | 193 | 288 | 8 | 9337bc93e3904c7fc7c93c328518bcd6453b1e8c | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-Mono-Mono_hypoxia-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.80e-05 | 193 | 288 | 8 | 5703a6faaee82cbad5ce73429bdf1b0f47b37ee0 | |
| ToppCell | droplet-Heart-nan-3m-Mesenchymal-fibroblast|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.94e-05 | 194 | 288 | 8 | ce32e60bcea1b8baf496ce9050832bc8c77d8434 | |
| ToppCell | droplet-Heart-nan-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.94e-05 | 194 | 288 | 8 | a1dc157148885cc8d3685ac81a1f4e3562aeecc9 | |
| ToppCell | LA-08._Macrophage|World / Chamber and Cluster_Paper | 3.94e-05 | 194 | 288 | 8 | c1805572bcc11b1cd29083329d7b5911489fb758 | |
| Drug | LY 294002; Down 200; 10uM; HL60; HT_HG-U133A | PER1 DGKA MPDZ PCGF3 RIN2 ATP11A MINAR1 DDX43 ZNF473 POLR2C AHCYL2 TEC XRCC4 RNF122 | 1.78e-07 | 196 | 283 | 14 | 2687_DN |
| Drug | Cromolyn disodium salt [15826-37-6]; Up 200; 7.8uM; MCF7; HT_HG-U133A | PER1 ATP8B1 BTG3 TRIB2 GNE APBB2 XRCC2 XRCC4 ZNF665 LTBP2 GREB1 RNF122 | 6.74e-06 | 196 | 283 | 12 | 3475_UP |
| Drug | Lithocholic acid [434-13-9]; Down 200; 10.6uM; PC3; HT_HG-U133A | PER1 ZZEF1 ITGB1 ATP11A KAT5 SYNE1 APBB2 XRCC4 ZNF711 TLE2 CAPN15 ZNF292 | 7.48e-06 | 198 | 283 | 12 | 4551_DN |
| Drug | Azathioprine [446-86-6]; Down 200; 14.4uM; MCF7; HT_HG-U133A | WDR62 CACNA1D GNE POLR2C TRIM3 TNFRSF11B OVOL1 ZNF277 CD40 ZFHX3 PLCH1 ZMYM6 | 7.48e-06 | 198 | 283 | 12 | 5262_DN |
| Disease | Malignant neoplasm of breast | CFL1 KBTBD8 PER1 ATP8B1 KEAP1 SULF2 PTPRC OTOGL EIF2S2 MTMR3 HERC2 FHL2 ALDOA NLRP8 VWF GFRAL SYNE1 NUP98 XRCC2 TECTA AR ZNF404 METTL6 ZNF277 CD40 MACF1 ATM ZNF281 | 1.43e-06 | 1074 | 279 | 28 | C0006142 |
| Disease | platelet component distribution width | PTBP1 ZZEF1 TRANK1 PTPRC RIN2 TMEM131L PDS5A ADGRF5 POLK TAP2 RHOF VAV1 USP49 VWF SYNE1 RTTN ZFPM2 ZNF710 ZMAT3 MACF1 ZNF333 XPO7 | 3.56e-06 | 755 | 279 | 22 | EFO_0007984 |
| Disease | Malignant neoplasm of prostate | PRSS8 ZBTB20 KEAP1 LRP1B TNFRSF21 PTPRC PDS5A POLK SPINK5 PSCA AHCYL2 AR TGFB1 LIFR ZFHX3 GREB1 ATM EPCAM ZNF292 | 7.55e-06 | 616 | 279 | 19 | C0376358 |
| Disease | Prostatic Neoplasms | PRSS8 ZBTB20 KEAP1 LRP1B TNFRSF21 PTPRC PDS5A POLK SPINK5 PSCA AHCYL2 AR TGFB1 LIFR ZFHX3 GREB1 ATM EPCAM ZNF292 | 7.55e-06 | 616 | 279 | 19 | C0033578 |
| Disease | osteoarthritis | 9.60e-06 | 222 | 279 | 11 | MONDO_0005178 | |
| Disease | carotid artery disease (is_marker_for) | 2.71e-05 | 19 | 279 | 4 | DOID:3407 (is_marker_for) | |
| Disease | Prostatic Cancer, Castration-Resistant | 6.74e-05 | 9 | 279 | 3 | C3658266 | |
| Disease | Prostatic Neoplasms, Castration-Resistant | 6.74e-05 | 9 | 279 | 3 | C3658267 | |
| Disease | Polycystic kidneys, severe infantile with tuberous sclerosis | 8.91e-05 | 2 | 279 | 2 | C1838327 | |
| Disease | urate measurement, bone density | WDR64 RHOBTB1 PTPRG GBP5 SULF1 A2ML1 ADAMTS16 KCNMA1 KCNS3 DNAH8 NUP153 SYNE1 THAP9 RANBP17 HEATR6 HELZ2 CABIN1 | 9.57e-05 | 619 | 279 | 17 | EFO_0003923, EFO_0004531 |
| Disease | Colorectal Carcinoma | ZBTB8B PER1 ZNF217 TXNRD1 MCM3AP DNAH8 NLRP8 SYNE1 POLE ADAMTSL3 TGFB1 LIFR GTF2B OSBP NAMPT P2RX7 EDRF1 ZNF292 | 1.41e-04 | 702 | 279 | 18 | C0009402 |
| Disease | autosomal dominant cerebellar ataxia (implicated_via_orthology) | 1.73e-04 | 12 | 279 | 3 | DOID:1441 (implicated_via_orthology) | |
| Disease | aspartate aminotransferase measurement, serum alanine aminotransferase measurement, low density lipoprotein triglyceride measurement, body fat percentage, high density lipoprotein cholesterol measurement, sex hormone-binding globulin measurement | ZBTB38 ZZEF1 NTNG2 SULF2 PTPRG TRIB2 PSCA ADAMTSL3 RANBP17 MACF1 ZFHX3 RPA1 | 2.00e-04 | 364 | 279 | 12 | EFO_0004612, EFO_0004696, EFO_0004735, EFO_0004736, EFO_0007800, EFO_0009946 |
| Disease | connective tissue disease (implicated_via_orthology) | 2.66e-04 | 3 | 279 | 2 | DOID:65 (implicated_via_orthology) | |
| Disease | Weill-Marchesani syndrome | 2.66e-04 | 3 | 279 | 2 | C0265313 | |
| Disease | Weill-Marchesani Syndrome, Autosomal Dominant | 2.66e-04 | 3 | 279 | 2 | C1869115 | |
| Disease | Weill-Marchesani Syndrome, Autosomal Recessive | 2.66e-04 | 3 | 279 | 2 | C1869114 | |
| Disease | Duchenne muscular dystrophy (implicated_via_orthology) | 3.63e-04 | 36 | 279 | 4 | DOID:11723 (implicated_via_orthology) | |
| Disease | Timothy syndrome (implicated_via_orthology) | 5.28e-04 | 4 | 279 | 2 | DOID:0060173 (implicated_via_orthology) | |
| Disease | Weill-Marchesani syndrome (is_implicated_in) | 5.28e-04 | 4 | 279 | 2 | DOID:0050475 (is_implicated_in) | |
| Disease | tyrosine-protein kinase TEC measurement | 5.28e-04 | 4 | 279 | 2 | EFO_0020830 | |
| Disease | conduct disorder (is_implicated_in) | 5.28e-04 | 4 | 279 | 2 | DOID:12995 (is_implicated_in) | |
| Disease | Weill-Marchesani syndrome | 5.28e-04 | 4 | 279 | 2 | cv:C0265313 | |
| Disease | Conventional (Clear Cell) Renal Cell Carcinoma | 5.39e-04 | 148 | 279 | 7 | C0279702 | |
| Disease | body fat percentage | ZBTB38 ZZEF1 NTNG2 SULF2 PTPRG KCNS3 TRIB2 PSCA ADAMTSL3 RANBP17 MACF1 ZFHX3 RPA1 | 8.33e-04 | 488 | 279 | 13 | EFO_0007800 |
| Disease | Geleophysic dysplasia | 8.74e-04 | 5 | 279 | 2 | C3489726 | |
| Disease | Sleep Disorders, Circadian Rhythm | 8.74e-04 | 5 | 279 | 2 | C0877792 | |
| Disease | Delayed Sleep Phase Syndrome | 8.74e-04 | 5 | 279 | 2 | C0393770 | |
| Disease | Nonorganic Sleep Wake Cycle Disorders | 8.74e-04 | 5 | 279 | 2 | C0494410 | |
| Disease | Acromicric Dysplasia | 8.74e-04 | 5 | 279 | 2 | C0265287 | |
| Disease | mucinous adenocarcinoma (is_marker_for) | 8.74e-04 | 5 | 279 | 2 | DOID:3030 (is_marker_for) | |
| Disease | paraplegia (biomarker_via_orthology) | 8.74e-04 | 5 | 279 | 2 | DOID:607 (biomarker_via_orthology) | |
| Disease | Shift-Work Sleep Disorder | 8.74e-04 | 5 | 279 | 2 | C0751760 | |
| Disease | Non-24 Hour Sleep-Wake Disorder | 8.74e-04 | 5 | 279 | 2 | C0751759 | |
| Disease | Advanced Sleep Phase Syndrome | 8.74e-04 | 5 | 279 | 2 | C0751758 | |
| Disease | free androgen index | PTPRG GML MINAR1 USP3 CACNA1D AR ZFPM2 PKNOX2 OVOL1 WDR11 GREB1 | 9.40e-04 | 374 | 279 | 11 | EFO_0007005 |
| Disease | immature platelet measurement | 9.63e-04 | 119 | 279 | 6 | EFO_0803541 | |
| Disease | non-melanoma skin carcinoma | 1.01e-03 | 265 | 279 | 9 | EFO_0009260 | |
| Disease | Epilepsy, Cryptogenic | 1.10e-03 | 82 | 279 | 5 | C0086237 | |
| Disease | Awakening Epilepsy | 1.10e-03 | 82 | 279 | 5 | C0751111 | |
| Disease | Aura | 1.10e-03 | 82 | 279 | 5 | C0236018 | |
| Disease | testosterone measurement | ZBTB20 NTNG2 PTPRG PLA2G12A ANAPC1 RIN2 EIF2B4 GML KCNS3 MINAR1 USP3 VIL1 CACNA1D KAT5 TTC27 AR ZFPM2 PKNOX2 OVOL1 WDR11 CEP112 MACF1 ZFHX3 GREB1 | 1.13e-03 | 1275 | 279 | 24 | EFO_0004908 |
| Disease | Curling Ulcer | 1.30e-03 | 6 | 279 | 2 | C0010474 | |
| Disease | Duodenal Ulcer | 1.30e-03 | 6 | 279 | 2 | C0013295 | |
| Disease | attempted suicide | 1.58e-03 | 178 | 279 | 7 | EFO_0004321 | |
| Disease | Brain Diseases | 1.65e-03 | 25 | 279 | 3 | C0006111 | |
| Disease | IGFBP-3 measurement | 1.71e-03 | 54 | 279 | 4 | EFO_0004626 | |
| Disease | functional impairment measurement | 1.81e-03 | 7 | 279 | 2 | EFO_0005412 | |
| Disease | Lymphopenia | 1.81e-03 | 7 | 279 | 2 | C0024312 | |
| Disease | lysosomal protective protein measurement | 1.81e-03 | 7 | 279 | 2 | EFO_0008215 | |
| Disease | Hereditary Nonpolyposis Colorectal Neoplasms | 1.85e-03 | 26 | 279 | 3 | C0009405 | |
| Disease | ceramide measurement | 1.87e-03 | 235 | 279 | 8 | EFO_0010222 | |
| Disease | Neoplasm Invasiveness | 1.91e-03 | 184 | 279 | 7 | C0027626 | |
| Disease | breast cancer (is_marker_for) | 1.97e-03 | 185 | 279 | 7 | DOID:1612 (is_marker_for) | |
| Disease | sexual dimorphism measurement | TRPC4AP ZBTB38 CFL1 TSC2 ZZEF1 FBN1 TRANK1 PTPRG EIF2S2 PKD1 VIL1 USP49 KAT5 ADAMTSL3 CERT1 ZNF710 OVOL1 ZNF341 MACF1 ZFHX3 LTBP2 | 2.06e-03 | 1106 | 279 | 21 | EFO_0021796 |
| Disease | Encephalopathies | 2.07e-03 | 27 | 279 | 3 | C0085584 | |
| Disease | Hereditary non-polyposis colorectal cancer syndrome | 2.07e-03 | 27 | 279 | 3 | C1112155 | |
| Disease | Dickkopf-related protein 4 measurement | 2.40e-03 | 8 | 279 | 2 | EFO_0008110 | |
| Disease | mesangial proliferative glomerulonephritis (biomarker_via_orthology) | 2.40e-03 | 8 | 279 | 2 | DOID:4783 (biomarker_via_orthology) | |
| Disease | Alcohol withdrawal syndrome | 2.40e-03 | 8 | 279 | 2 | C0236663 | |
| Disease | Hereditary Nonpolyposis Colorectal Cancer | 2.55e-03 | 29 | 279 | 3 | C1333990 | |
| Disease | peripheral arterial disease, traffic air pollution measurement | 2.58e-03 | 194 | 279 | 7 | EFO_0004265, EFO_0007908 | |
| Disease | Breast Cancer, Familial | 2.81e-03 | 30 | 279 | 3 | C0346153 | |
| Disease | suntan | 3.00e-03 | 103 | 279 | 5 | EFO_0004279 | |
| Disease | Liver Cirrhosis, Experimental | ZFYVE16 ITGB1 FBN1 PTPRC PLA2G12A FHL2 ZDHHC13 TAP2 VAV1 VWF ARL8A APP CRY1 TGFB1 PLPP2 EPCAM | 3.06e-03 | 774 | 279 | 16 | C0023893 |
| Disease | Hepatic Insufficiency | 3.07e-03 | 9 | 279 | 2 | C1306571 | |
| Disease | cognitive disorder (is_implicated_in) | 3.07e-03 | 9 | 279 | 2 | DOID:1561 (is_implicated_in) | |
| Disease | Malignant tumor of prostate | 3.07e-03 | 9 | 279 | 2 | cv:C0376358 | |
| Disease | Glaucoma | 3.07e-03 | 9 | 279 | 2 | C0017601 | |
| Disease | Intellectual Disability | ZMYND11 ZMYM2 NTNG2 CACNA1G WDR62 SYNE1 RTTN CERT1 MACF1 ZMYM6 ZNF292 | 3.76e-03 | 447 | 279 | 11 | C3714756 |
| Disease | Asthma, Occupational | 3.81e-03 | 10 | 279 | 2 | C0264423 | |
| Disease | anti-topoisomerase-I-antibody-positive systemic scleroderma | 3.81e-03 | 10 | 279 | 2 | EFO_0008537 | |
| Disease | Small Lymphocytic Lymphoma | 3.81e-03 | 10 | 279 | 2 | C0855095 | |
| Disease | Familial thoracic aortic aneurysm and aortic dissection | 3.81e-03 | 10 | 279 | 2 | cv:C4707243 | |
| Disease | Amyloidosis | 3.81e-03 | 10 | 279 | 2 | C0002726 | |
| Disease | B-CELL MALIGNANCY, LOW-GRADE | 3.81e-03 | 10 | 279 | 2 | C1868683 | |
| Disease | Epilepsy | 3.83e-03 | 109 | 279 | 5 | C0014544 | |
| Disease | Condition, Preneoplastic | 3.98e-03 | 110 | 279 | 5 | C0282313 | |
| Disease | Precancerous Conditions | 3.98e-03 | 110 | 279 | 5 | C0032927 | |
| Disease | Spinocerebellar Ataxia Type 2 | 4.03e-03 | 34 | 279 | 3 | C0752121 | |
| Disease | Spinocerebellar Ataxia Type 1 | 4.03e-03 | 34 | 279 | 3 | C0752120 | |
| Disease | Spinocerebellar Ataxia Type 5 | 4.03e-03 | 34 | 279 | 3 | C0752123 | |
| Disease | Spinocerebellar Ataxia Type 7 | 4.03e-03 | 34 | 279 | 3 | C0752125 | |
| Disease | Spinocerebellar Ataxia Type 6 (disorder) | 4.03e-03 | 34 | 279 | 3 | C0752124 | |
| Disease | Ataxia, Spinocerebellar | 4.03e-03 | 34 | 279 | 3 | C0087012 | |
| Disease | Spinocerebellar Ataxia Type 4 | 4.38e-03 | 35 | 279 | 3 | C0752122 | |
| Disease | age at menarche | ZBTB20 CFL1 RSF1 LRP1B ZNF518A ZNF331 SULF2 PTPRG USP35 USP49 ECPAS GREB1 CFAP61 | 4.59e-03 | 594 | 279 | 13 | EFO_0004703 |
| Disease | endometrial carcinoma, endometriosis | 4.63e-03 | 11 | 279 | 2 | EFO_0001065, EFO_1001512 | |
| Disease | polybrominated biphenyl measurement, gestational serum measurement, fetal genotype effect measurement, polybrominated diphenyl ether measurement | 4.63e-03 | 11 | 279 | 2 | EFO_0007959, EFO_0007961, EFO_0007962, EFO_0007964 | |
| Disease | Marfan Syndrome | 4.63e-03 | 11 | 279 | 2 | C0024796 | |
| Disease | immature platelet fraction | 4.63e-03 | 114 | 279 | 5 | EFO_0009187 | |
| Disease | eosinophilic esophagitis | 4.67e-03 | 163 | 279 | 6 | EFO_0004232 | |
| Disease | endometrial cancer (is_implicated_in) | 4.74e-03 | 36 | 279 | 3 | DOID:1380 (is_implicated_in) | |
| Disease | Neoplasm Metastasis | 4.76e-03 | 217 | 279 | 7 | C0027627 | |
| Disease | Abnormality of refraction | ZBTB38 PTBP1 ZZEF1 FBN1 MTMR3 KCNMA1 FRMPD2B MROH9 CACNA1D FAM76B ZMAT3 ZFHX3 SNTB1 FBN3 | 5.16e-03 | 673 | 279 | 14 | HP_0000539 |
| Disease | Breast Carcinoma | CFL1 EIF2S2 HERC2 FHL2 ALDOA SYNE1 XRCC2 AR ZNF404 METTL6 CD40 ATM | 5.49e-03 | 538 | 279 | 12 | C0678222 |
| Disease | Gastrointestinal Diseases | 5.52e-03 | 12 | 279 | 2 | C0017178 | |
| Disease | Functional Gastrointestinal Disorders | 5.52e-03 | 12 | 279 | 2 | C0559031 | |
| Disease | Cholera Infantum | 5.52e-03 | 12 | 279 | 2 | C1565321 | |
| Disease | brain disease (is_implicated_in) | 5.52e-03 | 12 | 279 | 2 | DOID:936 (is_implicated_in) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LVTQCNAKYVECFSA | 1156 | P23470 | |
| FVYRNSLCIENSCIA | 466 | Q15582 | |
| AAAQEECVCENYKLA | 21 | P16422 | |
| RSKLCSLYENDCIFD | 326 | Q00005 | |
| RSKLCSLYENDCIFD | 326 | Q9Y2T4 | |
| CRRTESQDVYCIKSL | 16 | Q8NHU2 | |
| KECGNYCLNTIIEAI | 821 | Q63HQ2 | |
| LTGRCELQRICYNTK | 31 | Q8N336 | |
| QANCYEEVKDRCTLA | 136 | P23528 | |
| CIRQLSYCKNDIRDT | 446 | Q92870 | |
| EECRACAEKTDYVNL | 156 | Q49AH0 | |
| DQKECAVECLYNNIV | 506 | Q96NH3 | |
| TCIDTKEGILQYCQE | 61 | P05067 | |
| SLEFQTEYLLCDCNI | 181 | Q8IWK6 | |
| EEYVKRALANSLACQ | 326 | P04075 | |
| TVQESFLVKICCRYT | 231 | A8K2U0 | |
| QEKAELERCYQITCS | 436 | Q8N8E3 | |
| RSKLCSLYENDCIFD | 336 | Q66LE6 | |
| YSDAEKVFLSCLQLC | 136 | Q92624 | |
| CRYFTDIIKCRVINT | 331 | O15484 | |
| ELLSSEACYECKING | 2666 | Q75N90 | |
| NCVTYFLQCLRTEKL | 466 | Q8N884 | |
| DFYLVVCSACNQVVK | 96 | Q9ULK2 | |
| FANETLRTLCLCYKE | 646 | O43520 | |
| TQVEDQDLCKLYCIA | 671 | Q8TE57 | |
| DKNCSLQRLNDSCIY | 446 | Q9BYT9 | |
| QLEQLCTVSRCEYEK | 441 | Q9H2T7 | |
| CEYEKTCALLVQLFD | 451 | Q9H2T7 | |
| CVVQTLKEYLESLQC | 206 | P49792 | |
| TFCRSCLVKYLEENN | 36 | Q3KNV8 | |
| TNEKLYTVCDVALCV | 1071 | Q29RF7 | |
| CVVQTLKEYLESLQC | 206 | Q99666 | |
| CVVQTLKEYLESLQC | 206 | O14715 | |
| CVCRKRDNTNEIYSG | 536 | P05556 | |
| CTQECSYFNITKVES | 661 | P05556 | |
| FARYVSAQRCNSKCV | 136 | O60268 | |
| VLICSYKCFTQRDPN | 326 | Q6ZNQ3 | |
| LAKQYSDRLECCENE | 41 | Q9Y5A7 | |
| SLCAEGAYQVRLCKD | 576 | O75808 | |
| AFYDNVCIIIALCRK | 611 | Q7Z5J8 | |
| SRCAVILYDIAQCEN | 801 | Q7Z5J8 | |
| AYSSNEVEKCICILQ | 141 | Q9H1A4 | |
| AIQDREICCYSISCK | 151 | Q9NVJ2 | |
| AIQDREICCYSISCK | 151 | Q96BM9 | |
| LCRQVDTLQKYFDAC | 171 | Q9Y5P4 | |
| RVCREYFSSSNCEKN | 241 | Q6IE37 | |
| DNKEIRTYNCSNCLT | 706 | Q8TAB3 | |
| CELDKNQRQCVEYAL | 1151 | O60840 | |
| LCDAVAAYAQACLDK | 1101 | Q6W4X9 | |
| EEFQYCLSKICRDVQ | 126 | Q9BZM1 | |
| YLANKCSIASRIDCF | 371 | O00567 | |
| LCSRIEQIQCYSAKD | 1726 | P52948 | |
| LDINVRTASKYDDCC | 1186 | Q14667 | |
| QYEILLKNRVGECSC | 791 | Q15746 | |
| AYCNQIKTSVFCRCK | 3816 | Q9NZR2 | |
| VCRCKQGYILNSDQT | 261 | O00339 | |
| NAIALQYCCTVADIK | 76 | Q7Z3D4 | |
| QYCCTVADIKRVNNL | 81 | Q7Z3D4 | |
| IESADACLILANKYC | 481 | Q12791 | |
| LAKTNYVVIICACRS | 541 | Q4ZG55 | |
| NAYQKLIECTDTFCT | 326 | Q10469 | |
| EVQVSAFCLKRCQYL | 641 | Q86W28 | |
| DLESQLSVSCKCYEA | 801 | Q3B7T1 | |
| LSVSCKCYEAANEIL | 806 | Q3B7T1 | |
| SVVDVCRVVYQAKCS | 1476 | O95714 | |
| CSEFRNYIRNNELIC | 916 | Q9NQ38 | |
| KDCLQNSLCEAEDRY | 341 | O76014 | |
| FVEAEEKVSYNCCRQ | 171 | A6NEK1 | |
| ETLQELQCFCKYLQR | 1231 | O60318 | |
| CTVCKISFNKVENYL | 856 | Q8WW38 | |
| SYSQNLCLLAKCFLD | 311 | Q92993 | |
| FIIIYGCDAVCTQQK | 1121 | Q8IVV2 | |
| ENECQNYKRCLEILE | 156 | Q14457 | |
| YICKLCASLDASVIA | 426 | O95786 | |
| LSKCAEQFCRLNEYN | 96 | P47710 | |
| IFCRTKIDCDNLEQY | 511 | Q92499 | |
| NAETQRCYRQELCKL | 1706 | Q5VYK3 | |
| ERKEASSCSYQQINC | 616 | O15534 | |
| LVFKYNVKACNSSCR | 1081 | Q7Z5P9 | |
| RCLGKYVVVFNCSDQ | 1861 | Q96JB1 | |
| VDLVTACDIRYCAQD | 176 | Q13011 | |
| SCTEGYRLAENQKSC | 156 | P00740 | |
| DCKATVIAEVYSQIC | 386 | Q8N819 | |
| KDVVCLNDVSCYFSL | 91 | P23743 | |
| EFKYCVSLRTQICQA | 1061 | Q6AI08 | |
| QTQREKIEACACQSY | 136 | Q8TBE9 | |
| KIEACACQSYFDAVV | 141 | Q8TBE9 | |
| CCLRKDVSCNLAVFY | 71 | A6NHS7 | |
| PIVKCTYCRSEFQQE | 36 | Q5HYJ3 | |
| FLCDCSEKAINRNYL | 71 | O95447 | |
| NDICKRNLEASSDYC | 391 | Q96PP8 | |
| LFIDSCCSNRYQERK | 111 | Q9BQ31 | |
| EACSNCIEAYQRLDR | 241 | O75949 | |
| KQKYLCASRNDCTID | 591 | P10275 | |
| CYSTVCVELDLQNLA | 1721 | Q07864 | |
| CNSNLKLEYKFCTRE | 671 | P23229 | |
| RVCREYFSSSNCEKN | 246 | Q6IE36 | |
| KCDQEIANCLAQTEY | 131 | O15496 | |
| SRVNCSVYVQLEKVC | 136 | O43688 | |
| KIVDAIYRQLCDNNC | 296 | Q5TGP6 | |
| VCCETYKFCERVQTD | 436 | Q9UI10 | |
| LQKDTRLYFLQCETC | 291 | P20042 | |
| SFLRECKVANYCRQV | 556 | Q9Y3T9 | |
| DRAAKCENSLEQLCY | 461 | P22059 | |
| AYVCCVRQLEVVKSS | 1151 | Q6ZV29 | |
| ECRNINRTYCDLSAE | 86 | Q9UHF4 | |
| LCCSQQQKATRVYAV | 251 | P35410 | |
| VCDYRQIEITICKND | 876 | Q9UPN3 | |
| LVQEKYLECCQVSNS | 246 | A6NCF6 | |
| DLFTCRVCQKAFTYQ | 116 | O14753 | |
| NSLKSVECYDSRENC | 406 | Q8NFY9 | |
| QNPLYDTERCKVFQC | 121 | Q8TCB7 | |
| DFVDLCCQAYNLIRK | 1256 | O00750 | |
| LSACAYVKDTDLSQC | 361 | Q5T6X5 | |
| CNFYDNKDLECVTNL | 246 | P10619 | |
| RCVVYEGNQKTCEVS | 151 | Q99572 | |
| IDQQNGLYRCEKCDT | 491 | P27694 | |
| CVVQTLKEYLESLQC | 206 | A6NKT7 | |
| EDTYRQVISCDKSVC | 41 | O95057 | |
| SCIYECIRNKIQCVS | 316 | O95876 | |
| VCSLYRRDQDVCKTI | 976 | Q13315 | |
| VCQTAVTYCKDALEN | 1501 | Q13315 | |
| NRNCSQLIAAYKDFC | 1941 | Q9ULT8 | |
| SQTFIYKCDAVLCTL | 611 | O60341 | |
| CTACSSKVLDQYERE | 646 | O95352 | |
| KDYRQCFECSDVALN | 751 | Q9Y6J0 | |
| RVCVATCNRADYSKL | 11 | Q9Y223 | |
| LQSVYECIARTCEKL | 61 | Q14410 | |
| RDLKKCYSVEAQSCQ | 2241 | O43497 | |
| DVVCNAQLASYLKAC | 141 | Q6UXV0 | |
| CLDNREGYCFTEVLQ | 2331 | P35555 | |
| TRVKGNNVYCLDREC | 571 | P53621 | |
| EDTYRQVISCDKSIC | 41 | Q96HU8 | |
| LEKDVRQNCYSVCDI | 286 | Q6IN97 | |
| LKECIQGADTIRCVY | 21 | Q16526 | |
| YVLCSSRDEKFQALC | 311 | Q9UMR2 | |
| VIQTSCQEGDQRCLY | 416 | Q9Y5Q5 | |
| AAKEDQLLCTDCYSN | 81 | Q14192 | |
| LCKDAECVNTRGSYL | 631 | Q14767 | |
| QKCEILQSDSRCKDY | 286 | Q14145 | |
| QEIEINYTRICANCA | 61 | A0ZSE6 | |
| NYTRICANCAKLREN | 66 | A0ZSE6 | |
| KNEATCLNEIGRYTC | 196 | P82279 | |
| VTLQYCCLTDDRQAF | 616 | Q9BYK8 | |
| LAEKTCVRKNENCYN | 296 | Q6UXH1 | |
| ALLCYSCKAQVSNED | 11 | O43653 | |
| ALLKYLCECQFDDNL | 121 | Q96T23 | |
| ELLVYKNCTNNCTFV | 66 | Q99445 | |
| VNELCKDFCNRYITC | 151 | Q96KN3 | |
| CELDKNQRQCVEYAL | 1166 | Q01668 | |
| RELALQVEGECCKYS | 326 | Q9NXZ2 | |
| IGDKICCTRNAYLSD | 776 | Q8NG08 | |
| STLCALQCLEKLYGD | 101 | O14772 | |
| VCIENRSRSCYQLEK | 81 | P42702 | |
| SQQLFEPSRVCKSCY | 1161 | Q13615 | |
| SAYVALCNKFDICIQ | 1781 | Q3ZCN5 | |
| VSLECVSCKAQAVYE | 2366 | P98161 | |
| QDKCDVSAVRDNYCR | 1701 | P56715 | |
| DCNYSNLEKILRESC | 871 | Q9P2E2 | |
| SYQDLCKSLCARFDL | 26 | Q9UPX6 | |
| YAISNIEVIGRCKCN | 276 | Q96CW9 | |
| AYVQNCVAASRCDDK | 456 | Q13835 | |
| KRTAEAVYSIECTCN | 541 | Q86VV8 | |
| RNCLYQNEECKEAAL | 1931 | Q86VV8 | |
| SCVSVENVLYVNCEK | 31 | Q8IW52 | |
| CVVQTLKEYLESLQC | 206 | Q7Z3J3 | |
| ACEQIRAALYLECSA | 161 | Q9HBH0 | |
| EISTACTYKNQECRL | 441 | Q13884 | |
| DSVTKQKFDNLYCCR | 361 | Q96HN2 | |
| QKFDNLYCCRESILD | 366 | Q96HN2 | |
| CELGRVYVSADLCQK | 2616 | A2VEC9 | |
| YCIVDSECKSRDVLQ | 566 | Q8TEL6 | |
| CKAYTDCLSQNLVVI | 186 | O75509 | |
| QNIYNACCTLRIDFS | 241 | Q9UKA9 | |
| CTCELKNFIQLETYS | 526 | Q9BXR5 | |
| SGLIKEYNCLCLQAS | 3041 | Q8NF91 | |
| VCQQLKGCYLESDDV | 241 | A2VDJ0 | |
| VELCYKNVNESCIKT | 11 | Q96RI9 | |
| TDGSYQCCRQTEKLA | 126 | P42680 | |
| DYLAAERTCVQSQKD | 1786 | A0AVI2 | |
| TENTRFCLICNYLSK | 146 | P40937 | |
| SVTKQKFDNLYCCRE | 281 | O43865 | |
| KCNLCYRVNDVPEEF | 451 | O95486 | |
| CRDCQEPYAINDSKV | 16 | A0A1B0GUV7 | |
| LLCSDLVKAYQRCVS | 216 | Q9BRQ6 | |
| TVYQQCVRCCRAFLE | 141 | P24666 | |
| LETDENRIYKQCFSC | 706 | Q86V20 | |
| EVCRYKEALEQCRQL | 351 | Q03519 | |
| TRDLLNCSFKCSYVV | 391 | P43490 | |
| DYCSICLQQYKRRQE | 1256 | Q8N3P4 | |
| CTNYNSVCSKFRKEI | 621 | O94844 | |
| SLAKRQVFCSVYCVE | 156 | Q8TC41 | |
| NVKDFLCQIERYCRQ | 131 | Q9BVR0 | |
| ISRETCNCLYNIDAK | 196 | Q16651 | |
| KQERSNCYCVCVERS | 51 | P61580 | |
| DDIVDKLQYSRDCTC | 76 | P19387 | |
| CLDVIRNKYECELQG | 126 | Q9HCU9 | |
| DVLKACENSCILYSD | 71 | Q14201 | |
| DNRYILCKTACVAAT | 1076 | Q8IZF2 | |
| IKEVERICRESSCYN | 741 | P53675 | |
| YERGQCDLELIKVCN | 921 | P53675 | |
| TQRYKEQLRELCCAV | 46 | Q8WW14 | |
| ATCYACKLFRRNTQL | 696 | P98196 | |
| YRNLVSLDISCKCVN | 41 | Q9H7R5 | |
| GAKCDYTIQVQLRFC | 181 | Q9Y6X2 | |
| VKCRCLDFNNEIYCQ | 281 | O75443 | |
| CYAKIICNTKDNERV | 571 | Q16881 | |
| NFQTEAICLVTCKKY | 116 | Q9BQY6 | |
| CFQKDVLNLVYLCEA | 276 | O60701 | |
| SYECLQCRNAFRLKS | 336 | Q8N184 | |
| LSRDKCTYFGCLVQD | 521 | Q8WYP3 | |
| NSNDVFVLKTQSCCY | 541 | P09327 | |
| RAYECDLCGNTFIQK | 361 | Q96PE6 | |
| VCKELQYVKQECNRT | 86 | O00300 | |
| KQVVLIDSSYLCQFC | 436 | Q9BYN7 | |
| LRANSSGLYKCELCE | 196 | Q9UID6 | |
| CDIVKATQYGIFERC | 51 | Q8IUH4 | |
| SVCKSYRETCQLRLE | 276 | P51449 | |
| LRAEGLECTKTCQNY | 781 | P04275 | |
| YLLEQSSLACNAECV | 981 | O75970 | |
| YKCELNGCNIVFSDL | 771 | Q13129 | |
| CCYFISKLRNQAQSE | 56 | Q9H9V4 | |
| CIDNEALYDICSKTL | 201 | Q3ZCM7 | |
| YVANKLSALLTCEDC | 721 | Q9H5L6 | |
| NDAIASACLYIACRQ | 156 | Q00403 | |
| NKNNYLREEECILAC | 286 | O43278 | |
| ELVCKVFDISCYQES | 86 | Q92519 | |
| FSSTEKNCCVRQLYI | 286 | P01137 | |
| YCESCASLQDAEKVV | 781 | Q9P2H5 | |
| CCCLREIQQTEEKYT | 196 | P15498 | |
| SLLICKYDFISLQCQ | 116 | Q5T0D9 | |
| YECVDCKALFASQEL | 126 | Q6ZN55 | |
| TNRALCYLKLCQFEE | 661 | Q07617 | |
| QAEAKCSICLDYLSD | 11 | A6NK02 | |
| LICYCLDTIAENQAK | 126 | Q13426 | |
| NKAEEQYSLCQELCS | 426 | Q9UBT6 | |
| AATDYCQQLCQTLLE | 46 | O60281 | |
| LNVCSVEEVCKTQAY | 636 | Q70CQ1 | |
| CQECGKAFTRVNYLT | 301 | Q9NQX6 | |
| QCLECDKSFHYRSQL | 436 | Q8N1W2 | |
| LCTDCQLNKLFYREE | 56 | Q96FA7 | |
| KCDTCQQYFSRTDRL | 346 | Q9Y2X9 | |
| FEEQLNYSIVCLKCE | 186 | Q70EL3 | |
| AENAVYLCDREACFK | 686 | O00507 | |
| ILNFSCLKCRDNTRY | 116 | Q6AHZ1 | |
| LVKCDICNNESVYTL | 176 | Q6AHZ1 | |
| QRYFNKNEDVCSCST | 56 | P49790 | |
| VVEYCDAEKSNFTLC | 156 | Q8IYL9 | |
| LYECEECRKAFIQSS | 351 | Q3KNS6 | |
| EDIACNFESKYQCIS | 1501 | Q4KWH8 | |
| CQLEASACYVFTEQL | 561 | Q6ZN44 | |
| CSQCLEKLVNDYRLV | 176 | O43543 | |
| CDNCYEARNVQLAVT | 651 | Q9HBF4 | |
| RKIYCVACQELDSDV | 66 | O60232 | |
| VRAYQCSICNKRFTQ | 631 | Q9HC78 | |
| AAAKAALIYTCTVCR | 31 | Q9Y5V0 | |
| EKLYECATCGQVLSR | 531 | Q96JL9 | |
| CEQCEKAFVRSYLLV | 301 | Q494X3 | |
| KVLNYCRIFTELCET | 291 | Q9Y5L0 | |
| CEECGKRFTQNSQLY | 486 | Q9UK10 | |
| KRFCCQSCVSEYKQV | 491 | Q9UBW7 | |
| CVSYSGLLCQFNEKR | 271 | O43379 | |
| SLSNIEQFCCYFKEL | 176 | Q9Y6I4 | |
| ELDELQLCKNCFYLS | 251 | Q15326 | |
| ELFCSINCLSAYRVK | 296 | O95789 | |
| YECDKVFSRNSCLAL | 351 | Q09FC8 | |
| LDNLQCLYCEKTFRD | 221 | Q9NRM2 | |
| VDSSRCYQCVKFLVT | 2491 | Q9UPU5 | |
| CQECRKAFSQIAYLA | 416 | Q96NI8 | |
| RCEYEKTCALLVQLF | 451 | Q9UIA9 | |
| YVQINIKRCLSDGCD | 356 | O43149 | |
| ILATENDYCKLCDAS | 141 | Q9HA38 | |
| CEFCEYAAAQKTSLR | 501 | O75362 | |
| CESIYQKLCEILETN | 766 | Q5TAH2 | |
| NECQKLFCYRTSLIR | 296 | P0CG24 | |
| CTLSQCFQLYTKEER | 596 | Q70CQ4 | |
| TSRPYACELCAKQFQ | 1006 | Q8NAP3 | |
| DTYQNECFLRRAACK | 116 | Q8IYR6 | |
| CLSYAKEFQLSAQLC | 1776 | O15050 | |
| CLIDKAADACRYLQT | 1071 | Q9BZH6 | |
| KDCSQRNDVVYVCRV | 211 | Q96PF1 | |
| TTSVLERLKIFYCCQ | 421 | Q6P3X3 | |
| QYCIFRCADQSNLKT | 536 | Q9Y462 | |
| VKELCQQARYQTACE | 441 | Q8IWU6 | |
| QLDCLNRDNYIRSCK | 496 | Q04725 | |
| IYNACCTLRIDFSKL | 246 | P26599 | |
| VTRCEEGNRNKCAEY | 751 | P08575 | |
| RVKDLCQRAEYQTAC | 441 | Q8IWU5 | |
| CLATTQRKIFQCDEY | 136 | Q5JVG8 | |
| VCKYNECGRTFIESL | 241 | Q8NDW4 | |
| CREKQYLINSQCCSL | 26 | P25942 | |
| VCVVCYETISKAQAF | 796 | Q7Z3T8 | |
| LDYECNLVSLQCRKD | 1676 | P49815 | |
| DKQFLVCSICLDRYQ | 16 | O75382 | |
| KCDICEQSFEQRSYL | 196 | Q8IZ26 | |
| ANTFCYCVKANVIVT | 326 | B1ANS9 | |
| CSKCDRVFTQRNYLV | 676 | Q8WTR7 | |
| YRCNQCSLAFKTIEK | 1401 | Q15911 | |
| CNECEKAFSYQSDLL | 111 | Q9UJN7 | |
| VNFCKTYIRSSLDIC | 111 | Q8NAP8 | |
| SLDRYKQRCCQSCQE | 1676 | P82987 | |
| CQQALTTSCYFRDRK | 86 | O60663 | |
| LRDEIYCQICKQLSE | 1106 | Q6PIF6 | |
| NIDYIDNTCCINLIS | 586 | B2RTY4 |